Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this ch
apter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
PART
I
ITEM
1. DESCRIPTION OF BUSINESS.
General
Business Development
Corporate
History
Agritek
Holdings, Inc. (referred to hereafter as “AGTK,” or, the “Company”), was initially incorporated under
the laws of the State of Delaware in 1997 under the name Easy Street Online, Inc.
In
1997, the Company changed its name to Frontline Communications Corp. (“Frontline”) and operated as a regional Internet
service provider (“ISP”) providing Internet access, web hosting, website design, and related services to residential
and small business customers throughout the Northeast United States and, through a network partnership agreement, Internet access
to customers nationwide.
On
April 3, 2003, the Company acquired Proyecciones y Ventas Organizadas, S.A. de C.V. (“Provo Mexico”) and in December
2003 the Company changed the name to Provo International Inc. (“Provo”).
In
2008, Provo changed its name to Ebenefits Direct, Inc., which, through its wholly-owned subsidiary, L.A. Marketing Plans, LLC,
engaged in the business of direct response marketing. The Company’s principal business was to market and sell non-insurance
healthcare programs designed to complement medical insurance products and to provide savings for those who cannot afford or qualify
for traditional health insurance products.
On
October 14, 2008, Ebenefits Direct, Inc. changed its name to Seraph Security, Inc. (“Seraph”).
On
April 25, 2009, Seraph acquired Commerce Online Technologies, Inc., a credit and debit card processing company.
On
May 20, 2009, Seraph Security, Inc. changed its name to Commerce Online, Inc. to more accurately reflect its core business of
merchant processing, and financial services.
As
of February 18, 2010, Commerce Online, Inc. changed its name to Cannabis Medical Solutions, Inc. (“CMSI”) as a provider
of merchant processing payment technologies for the medical marijuana and wellness sector.
On
March 8, 2010, the Company completed the acquisition of 800 Commerce, Inc. (“800 Commerce”) a Florida Corporation
incorporated by the Company’s Chief Executive Officer. The company issued 1,000,000 shares of common stock to 800 Commerce
for all the issued and outstanding stock of 800 Commerce, Inc.
In
June 2010, 31,288,702 shares of common stock were issued as dividend shares (the “dividend”) to all existing shareholders
of common stock of record.
On
June 14, 2011, Cannabis Medical Solutions, Inc. changed its merchant name to MediSwipe Inc. (“MWIP”) as a result of
its focus on the processing and financial services related to medical marijuana business.
On
June 26, 2013, the Company formed American Hemp Trading Company, a wholly owned subsidiary.
On
June 26, 2013, the Company formed Agritech Innovations, Inc. (“AGTI”), a wholly owned subsidiary. On September 3,
2013, AGTI changed its name to Agritech Venture Holdings, Inc. (“AVH”).
On
November 12, 2013, the Board of Directors of the Company approved a 1-for-10 reverse stock split (the “Reverse Stock Split”)
and a decrease in the authorized common stock of the Company to 250,000,000. Pursuant to the Reverse Stock Split, each 10 shares
of the Company’s common stock automatically converted into one share of Company common stock.
On
November 12, 2013, the Financial Industry Regulatory Authority (“FINRA”) approved the Reverse Stock Split with an
effective date of December 11, 2013. All the share amounts in this annual report on Form 10-K reflect the Reverse Stock Split.
On
April 23, 2014, MWIP changed its name to Agritek Holdings, Inc. (“AGTK”) to more properly reflect the Company’s
current business model.
On
May 27, 2014, AVH changed its names to Agritek Venture Holdings, Inc. (“AVHI”).
On
August 27, 2014, American Hemp Trading Company changed its name to Prohibition Products, Inc. (“PPI”)
Unless
otherwise noted, references in this Form 10-K to “Seraph,” “Commerce Online, Inc.,” “Cannabis Medical
Solutions,” “Mediswipe,” the “Company,” “we,” “our” or “us”
means Agritek Holdings, Inc.
Description
of Business
Agritek
Holdings Inc. (“the Company” or “Agritek Holdings”) is a fully integrated, active investor and operator
in the legal cannabis sector. Specifically, Agritek Holdings provides strategic capital and functional expertise to accelerate
the commercialization of its diversified portfolio of holdings. Currently, the Company is focused on three high-value segments
of the cannabis market, including real estate investment, intellectual property brands; and infrastructure, with operations in
three U.S. States, Colorado, Washington State, California as well as Canada and Puerto Rico. Agritek Holdings invests its capital
via real estate holdings, licensing agreements, royalties and equity in acquisition operations.
Agritek
Holdings Inc. has organized its interests across three business units – Agritek Venture Holdings; The American Hemp Trading
Company; and MediSwipe, Inc. Agritek Venture Holdings includes the Company’s real estate portfolio, controlled equity holdings,
minority equity holdings and royalty interests. Subsidiary operations also includes a portfolio of wholly owned and licensed brands
that cover high growth segments of the cannabis sector including vaping, pre-rolls, edibles, topicals, medical devices, concentrates
and animal health. MediSwipe, Inc. offers a suite of services including corporate finance, marketing & branding, operational
support, financial management, and compliance & regulatory. These services are offered by a strong in-house team complemented
by independent advisors with the objective of assisting clients and partners in accelerating the commercialization of their product(s)
or services, and ultimately in leveraging their unique selling proposition to create a leadership position in their chosen niche
within the global cannabis industry.
Agritek
Holdings Inc. intends to build on its existing relationships by developing operating plans and providing oversight, strategy and
management of the business units’ growth and integration. Further, Agritek Holdings plans to continue expanding its reach
by building new partnerships with vertical market partners and end- user products companies as well as exploring opportunities
with successful cultivators and processors. Through its expansion efforts, Agritek Holdings intends to utilize online sales and
marketing platforms, participate in relevant trade shows and develop various advertising materials to communicate its multiple
licensed brands including “California Premiums”, “Hemp Pops” and additional CBD products.
Agritek
Holdings is also well-positioned to participate in the large and growing legal cannabis market for enhanced downstream cannabis
products and new products with various consumer and medical applications.
Agritek
Holdings focuses on the growth of its business units and expanding their reach to end-users and partners. Although the business
units are primarily responsible for developing and operating their respective businesses, Agritek Holdings is available to provide
functional expertise, financing, oversight and a framework of disciplined planning to the operations of the business units when
needed.
Agritek
Holdings’ short-term objective is to create a sustainable business in the key states of California, Colorado, Washington
and Oregon as well as in Canada and Puerto Rico by integrating its holdings to create synergies and true end-to-end solutions
geared to the needs of patients and consumers. Agritek Holdings has positioned itself for commercial growth by focusing its expanded
resource base on finding and partnering with the best and most innovativ
e
companies, projects, assets and overall business frameworks in the legal cannabis sector in the aforementioned jurisdictions.
To
achieve its objectives, the Company will continue making specific and deliberate investments, including acquisitions, to:
|
1.
|
Increase
the diversity and quality of the Company’s product offerings across different market
segments; and
|
|
2.
|
Increase
the strength and segmentation of the Company’s diversified portfolio of real estate
holdings and product brands.
|
In
addition, management believes that significant opportunities exist today and will develop further in the future, to leverage the
Company’s expertise, financial strength and business model in legal cannabis markets around the world. Agritek Holdings
intends on pursuing opportunities in a number of jurisdictions where cannabis use is legal, and/or where governments are actively
pursuing legalization.
Subject
to legislative and regulatory compliance, strategic business opportunities pursued by the Company could include:
|
1.
|
Providing
advisory services to third-parties that are interested in establishing licensed cannabis
cultivation, processing and sales operations;
|
|
2.
|
Entering
into strategic relationships that create value by sharing expertise and industry knowledge;
|
|
3.
|
Providing
capital in the form of debt, royalties, or equity to new business units; and
|
|
4.
|
Entering
into licensing agreements to generate revenue, create strategic partnerships, or other
business opportunities.
|
Agritek
Holdings and its wholly-owned subsidiaries, MediSwipe, Inc., Prohibition Products Inc., and Agritek Venture Holdings, Inc. provide
turnkey support solutions to the legal cannabis industry. We provide key business services to the legal cannabis sector including:
•
|
Funding and Financing Solutions for
Agricultural Land and Properties zoned for the regulated Cannabis Industry.
|
•
|
Dispensary and Retail Solutions
|
•
|
Commercial Production and Equipment Build Out
Solutions
|
•
|
Banking and Payment Processing Solutions
|
•
|
Multichannel Supply Chain Solutions
|
•
|
Branding, Marketing and Sales Solutions of proprietary
product lines
|
•
|
Consumer Product Solutions
|
The
Company intends to bring its’ array of services to each new state that legalizes the use of cannabis according to appropriate
state and federal laws. Our primary objective is acquiring commercial properties to be utilized in the commercial marijuana industry
as cultivation facilities in compliance with state law. This is an essential aspect of our overall growth strategy because once
acquired and re-zoned, the value of such real property is substantially higher than under the previous zoning and use.
Once
properties are identified and acquired to be used for purposes related to the commercial marijuana industry as provided for by
state law, and we plan to create vertical channels within that legal jurisdiction including equipment financing, payment processing
and marketing of exclusive brands and services to retail dispensaries
Agritek’s
business focus is primarily to hold, develop and manage real property. The Company shall also provide oversight on every property
that is part of its portfolio. This can include complete architectural design and subsequent build-outs, general support, landscaping,
general up-keep, and state of the art security systems. At this time, Agritek does not grow, process, own, handle, transport,
or sell marijuana as the Company is organized and directed to operate strictly in accordance with all applicable state and federal
laws.
Services and
Markets
To
date, we have purchased eighty (80) acres approved for licenses and cultivation in Pueblo, Colorado. We have multiple manufacturing
and service contracts in place in areas in the following sectors:
Funding and
Financing Solutions
Our
goal is to become the funding and financing service partner of choice in the legal Colorado and California cannabis market before
expanding nationwide if and when applicable state and federal laws allow us to do so. We offer financing and financial aid
to cultivators, collectives, dispensaries and product businesses in the legal cannabis industry with alternative funding and financing
solutions. In the evolving legal cannabis industry, where traditional banking opportunities are grossly limited, we step in to
provide the “traditional” bank lending services; lines of credit, property financing, and/or commercial loans. Businesses
and individuals seeking funding and financing solutions are qualified and scored based on their experience, current operations,
financial records, and compliance grades given by our proprietary banking partners and credit lines that comply with all state
governance rules.
Commercial
Build Out and Dispensary Solutions
We
offer turnkey build-out and commercial services to our clients. Whether it is financial assistance, real estate consulting, operations
design, or building construction, our Company can design and rollout customized services for our clients. We also offer traditional
business services to dispensaries as well. These services include infrastructure investment, technology partners, donation accounting,
payment processing and succession strategies. It is important to note that we are not a “one size fits all” organization,
but are committed to custom tailored solutions for legal cannabis industry participants.
Finance
and Real Estate
Real
Estate Leasing
Our
real estate leasing business primarily includes the acquisition and leasing of cultivation space and related facilities to licensed
marijuana growers and dispensary owners for their operations. Management anticipates that these facilities will range in size
from 5,000 to 50,000 square feet. These facilities will only be leased to tenants that possess the requisite state licenses to
operate cultivation facilities. The leases with the tenants will provide certain requirements that permit us to continually evaluate
our tenants’ compliance with applicable laws and regulations.
As
of the date of this report, we own one cultivation property that is located in a suburb of Pueblo, Colorado (the “Pueblo
West Property”). The property consists of approximately eighty (80) acres of land. The property is currently zoned for cultivating
cannabis and is expected to be leased to a medical cannabis cultivator or manufacturer this year. We are currently evaluating
strategic options for this property.
Shared
Office Space, Networking and Event Services
We
plan to continue to acquire commercial real estate and lease office space to participants in the cannabis industry. These participants
include media, internet, packaging, lighting, cultivation supplies, and financial services. In exchange for certain services that
may be provided to these tenants, we expect to receive rental income. In certain cases, we may acquire equity interests or provide
debt capital to these businesses and eventually acquire a specific business as a wholly owned subsidiary of Agritek.
Industry
Finance and Equipment Leasing Services
We
plan to lease cultivation equipment and facilities to customers in the cannabis industry. We expect we will enter into sale lease-back
transactions of land zoned for cultivation, green houses, grow lights, tenant improvements and other grow equipment. Since Colorado
State law does not allow entities operating under a cannabis license to pledge the assets or the license of the cannabis operation
for any type of general borrowing activity, we intend to provide loans to individuals and businesses in the cannabis industry
on an unsecured basis. Equipment will only be leased to tenants that possess the requisite state licenses to operate such
facilities. The leases with the tenants will provide certain requirements that permit us to continually evaluate its tenants’
compliance with applicable laws and regulations.
Our
finance strategy will include making direct term loans and providing revolving lines of credit to businesses involved in the cultivation
and sale of cannabis and related products. These loans will generally be secured to the maximum extent permitted by law.
We believe there is a significant demand for this financing. We are pursuing other finance services including customized
finance, capital formation, and banking, for participants in the cannabis industry.
Competitive
Strengths
We
believe we possess certain competitive strengths and advantages in the industries which we operate:
Range
of Services:
We are able to leverage our breadth of services and resources to deliver a comprehensive, integrated
solution to companies in the cannabis industry – from operational and compliance consulting to security and marketing to
financing needs.
Strategic
Alliances.
We are dedicated to rapid growth through acquisitions, partnerships and agreements that will enable us to
enter and expand into new markets. Our strategy in pursuing these alliances are based on the target’s ability to generate
positive cash flow, effectively meet customer needs, and supply desirable products, services or technologies, among other considerations.
We anticipate that strategic alliances will play a significant role as more states pass legislation permitting the cultivation
and sale of hemp and cannabis.
Industry’s
Access to Capital.
In February 2014, the Treasury Department issued guidelines for financial institutions dealing with
cannabis-related businesses, (see “FinCEN” under “Federal Regulations and Our Business” of this document).
In March 2015, legislation was introduced in the U.S. Senate proposing to change federal law such that states could regulate medical
use of cannabis without risk of federal prosecution. A key component of the proposed Compassionate Access, Research Expansion,
and Respect States Act (the “CARERS Act”) is to reclassify cannabis under the Controlled Substances Act to Schedule
II, thereby changing the plant from a federally-criminalized substance to one that has recognized medical uses. Many banks and
traditional financial institutions refuse to provide financial services to cannabis-related business. We plan to provide finance
and leasing solutions to market participants using the FinCEN guidelines as a primary guide for compliance with federal law.
Regulatory
Compliance.
The state laws regulating the cannabis industry are changing at a rapid pace. Currently, there are twenty-six
U.S. states and the District of Columbia that have created a legislative body to manage the medical cannabis industry. There are
also five states that have allowed recreational use. In Colorado and Washington states, cannabis is heavily regulated. It is a
critical component of our business plan both to ensure that all aspects of our operations are in compliance with all laws, policies,
guidance and regulations to which we are subject and to provide an opportunity to our customers and allies to use our services
to ensure that they, too, are in full compliance.
Industry
Breadth.
We continue to create, share and leverage information and experiences with the purpose of creating awareness
and identifying opportunities to increase shareholder value. Our management team has extensive knowledge of the cannabis industry
and closely monitors changes in legislation. We work with partners who enhance our industry breadth.
Intellectual
Property
On
November 17, 2016, we filed with the United States Patent and Trademark Office (“USPTO”) a federal trademark registration
for “Hemp Pops” in the category of Staple Food Products.
Competition
Currently,
there are a number of other companies that provide similar products and/or services, such as direct finance, leasing of real estate,
including shared workspace, warehouse sales, and consulting services to the cannabis industry. In the future we fully expect that
other companies will recognize the value of ancillary businesses serving the cannabis industry and enter into the marketplace
as competitors.
The
cannabis industry in the United States is highly fragmented, rapidly expanding and evolving. The industry is characterized by
new and potentially disruptive or conflicting legislation propounded on a state-by-state basis. Our competitors may be local or
international enterprises and may have financial, technical, sales, marketing and other resources greater than ours. These companies
may also compete with us in recruiting and retaining qualified personnel and consultants.
Our
competitive position will depend on our ability to attract and retain qualified underwriters, investment banking partners and
loan managers, consultants and advisors with industry depth, and talented managerial, operational and other personnel. Our competitive
position will also depend on our ability to develop and acquire effective proprietary products and solutions, personal relationships
of our executive officers and directors, and our ability to secure adequate capital resources. We compete to attract and retain
customers of our services. We expect to compete in this area on the basis of price, regulatory compliance, vendor relationships,
usefulness, availability, and ease of use of our services.
Government
Regulation
As
of January 31, 2018, there are 30 states plus the District of Columbia that have laws and/or regulation that recognize in one
form or another legitimate medical uses for cannabis and consumer use of cannabis in connection with medical treatment. Many other
states are considering similar legislation. Conversely, the federal government regulates drugs through the Controlled Substances
Act (“CSA”), which does not recognize the difference between medical and recreational use of cannabis. Under federal
law, cannabis is treated like every other controlled substance, such as cocaine and heroin. The federal government places every
controlled substance in a schedule, in principle according to its relative potential for abuse and medicinal value. Under the
CSA, cannabis is classified as a Schedule I drug, which means that the federal government views medical cannabis as highly addictive
and having no medical value. Pursuant to the CSA, it is unlawful for any person (1) to sell or offer for sale drug paraphernalia;
(2) to use the mails or any other facility of interstate commerce to transport drug paraphernalia; or (3) to import or export
drug paraphernalia.
The
extent to which the regulation of drug paraphernalia under the CSA is applicable to our business and the sale of our product is
found in the definition of drug paraphernalia. Drug paraphernalia means any equipment, product, or material of any kind which
is primarily intended or designed for use in manufacturing, compounding, converting, concealing, producing processing, preparing,
injecting ingesting, inhaling or otherwise introducing into the human body a controlled substance, possession of which is unlawful.
Our products are primarily designed for general agricultural use.
The
United States Congress previously used the rider provision in the fiscal years 2015, 2016, and 2017 known as the Consolidated
Appropriations Acts (formerly the Rohrabacher-Farr Amendment) to thwart the federal government from using congressionally appropriated
funds to prevent states from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical
marijuana. The “Consolidated Appropriations Act, 2018” now known as the “Leahy Amendment,” is a
$1.3 trillion-dollar spending bill, which will now allow continued protections for the implementation of state medical marijuana
programs through fiscal year end, September 30, 2018.
The
2018 appropriations protection, continues this provision to 46 states, the District of Columbia, Guam, and Puerto Rico, with the
exclusion of Idaho, Kansas, Nebraska, and South Dakota. The 2018 spending bill also continues existing provisions shielding state
industrial hemp research programs from federal interference.
FinCEN
The
Financial Crimes Enforcement Network (“FinCEN”) provided guidance on February 14, 2014 about how financial institutions
can provide services to cannabis-related businesses consistent with their Bank Secrecy Act (“BSA”) obligations. For
purposes of the FinCEN guidelines, a “financial institution” includes any person doing
business
in one or more of the following capacities:
|
•
|
Bank
(except bank credit card systems);
|
|
•
|
Broker
or dealer in securities;
|
|
•
|
Money
services business;
|
|
•
|
A
person sub
ject to supervision by any
state or federal bank supervisory authority.
|
In
general, the decision to open, close, or refuse any particular account or relationship should be made by each financial institution
based on a number of factors specific to that institution. These factors may include its particular business objectives, an evaluation
of the risks associated with offering a particular product or service, and its capacity to manage those risks effectively. Thorough
customer due diligence is a critical aspect of making this assessment.
In
assessing the risk of providing services to a cannabis-related business, a financial institution should conduct customer due diligence
that includes: (i) verifying with the appropriate state authorities whether the business is duly licensed and registered; (ii)
reviewing the license application (and related documentation) submitted by the business for obtaining a state license to operate
its cannabis-related business; (iii) requesting from state licensing and enforcement authorities available information about the
business and related parties; (iv) developing an understanding of the normal and expected activity for the business, including
the types of products to be sold and the type of customers to be served (e.g., medical versus recreational customers); (v) ongoing
monitoring of publicly available sources for adverse information about the business and related parties; (vi) ongoing monitoring
for suspicious activity, including for any of the red flags described in this guidance; and (vii) refreshing information obtained
as part of customer due diligence on a periodic basis and commensurate with the risk. With respect to information regarding state
licensure obtained in connection with such customer due diligence, a financial institution may reasonably rely on the accuracy
of information provided by state licensing authorities, where states make such information available.
As
part of its customer due diligence, a financial institution should consider whether a cannabis-related business violates state
law. This is a particularly important factor for a financial institution to consider when assessing the risk of providing financial
services to a cannabis-related business. Considering this factor also enables the financial institution to provide information
in BSA reports pertinent to law enforcement’s priorities. A financial institution that decides to provide financial services
to a cannabis-related business would be required to file suspicious activity reports.
While
we believe we do not qualify as a financial institution in the United States, we cannot be certain that we do not fall under the
scope of the FinCEN guidelines. We plan to use the FinCEN Guidelines, as may be amended, as a basis for assessing our relationships
with potential tenants, clients and customers. As such, as we engage in financing activities, we intend to adhere to the guidance
of FinCEN in conducting and monitoring our financial transactions. Because this area of the law is uncertain but expected to evolve
rapidly, we believe that FinCEN’s guidelines will help us best operate in a prudent, reasonable and acceptable manner. There
is no assurance, however, that our activities will not violate some aspect of the CSA. If we are found to violate the federal
statute or any other in connection with our activities, our company could face serious criminal and civil sanctions.
We
intend to conduct rigorous due diligence to verify the legality of all activities that we engage in. We realize that there is
a discrepancy between the laws in some states, which permit the distribution and sale of medical and recreational cannabis, from
federal law that prohibits any such activities. The CSA makes it illegal under federal law to manufacture, distribute, or dispense
cannabis. Many states impose and enforce similar prohibitions. Notwithstanding the federal ban, as of the date of this filing,
twenty-six states and the District of Columbia have legalized certain cannabis-related activity.
Moreover,
since the use of cannabis is illegal under federal law, we may have difficulty acquiring or maintaining bank accounts and insurance
and our stockholders may find it difficult to deposit their stock with brokerage firms.
Employees
Other
than the Company’s sole officer and director, we do not have any full-time employees. The Company relies on several independent
contractors and other agreements it has with other companies to provide the services needed. Each contractor has been carefully
selected to address immediate needs in particular functional areas, but also with consideration of the Company’s future
needs during a period of expected rapid growth and expansion. Value is placed not only on outstanding credentials in specific
areas of functional expertise, but also on cross-functionality, a strong knowledge of content acquisition and distribution, along
with hands-on experience in scaling operations from initial beta and development stage through successful commercial deployment.
Corporate
Contact Information
Our
principal executive offices are located at 777 Brickell Avenue Suite 500, Miami, Florida 33131; Telephone No.: (305) 721-2727.
Our website is located at
http://www.AgritekHoldings.com
.
The content on our website is available for informational
purposes only. It should not be relied upon for investment purposes, nor is it incorporated by reference into this Form 10-K.
Available
Information
The
public may read and copy any materials we file with the SEC, including our annual reports, quarterly reports, current reports,
proxy statements, information statements and other information, at the SEC’s Public Reference Room at 100 F Street, NE,
Washington, DC 20549, on official business days during the hours of 10 a.m. to 3 p.m. The public may obtain information on the
operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains
reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at
http://www.sec.gov
.
ITEM
1A – RISK FACTORS
You
should carefully consider the risks described below, as well as other information provided to you in this document, including
information in the section of this document entitled “Forward-Looking Statements.” The risks and uncertainties described
below are not the only ones facing the Company. If any of the following risks actually occur, the Company’s business, financial
condition or results of operations could be materially adversely affected.
Investors
should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as
of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect
events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated
events or circumstances. Our business, financial condition and/or results of operation may be materially adversely affected by
the nature and impact of these risks. New factors emerge from time to time, and it is not possible for us to predict all of such
factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor,
or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
Risk
Related to Our Company
Our
independent auditors have expressed substantial doubt about our ability to continue as a going concern.
We
incurred a net loss of $9,153,310 and $2,977,889 for the years ending December 31, 2017 and 2016, respectively. Because of our
continued operating losses, negative cash flows from operations and working capital deficit, in their report on our financial
statements for the year ended December 31, 2017, our independent auditors included an explanatory paragraph regarding their substantial
doubt about our ability to continue as a going concern. We will continue to experience net operating losses in the foreseeable
future. Our ability to continue as a going concern is subject to our ability to generate a profit and/or obtain necessary funding
from outside sources, including obtaining additional funding from the sale of our securities, increasing sales or obtaining loan
from various financial institutions where possible. Our continued net operating losses increase the difficulty in meeting such
goals and there can be no assurances that such methods will prove successful.
Federal
regulation and enforcement may adversely affect the implementation of medical marijuana laws and regulations may negatively impact
our revenues and profits.
Currently,
there are 30 states plus the District of Columbia that have laws and/or regulation that recognize in one form or another legitimate
medical uses for cannabis and consumer use of cannabis in connection with medical treatment. Many other states are considering
similar legislation. Conversely, under the Controlled Substances Act (the “CSA”), the policy and regulations of the
Federal government and its agencies is that cannabis has no medical benefit and a range of activities including cultivation and
use of cannabis for personal use is prohibited. Until Congress amends the CSA with respect to medical marijuana, there is a risk
that federal authorities may enforce current federal law, and we may be deemed to be facilitating the selling or distribution
of drug paraphernalia in violation of federal law. Active enforcement of the current federal regulatory position on cannabis may
thus indirectly and adversely affect revenues and profits of the Company. The risk of strict enforcement of the CSA in light of
congressional activity, judicial holdings and stated federal policy remains uncertain.
Federal
authorities have not focused their resources on such tangential or secondary violations of the Act, nor have they threatened to
do so, with respect to the leasing of real property or the sale of equipment that might be used by medical cannabis gardeners,
or with respect to any supplies marketed to participants in the emerging medical cannabis industry. We are unaware of such a broad
application of the CSA by federal authorities, and we believe that such an attempted application would be unprecedented.
The
Company may provide services to and potentially handle monies for businesses in the legal cannabis industry.
Selling
or distributing medical or retail cannabis is deemed to be illegal under the Federal Controlled Substances Act even though such
activities may be permissible under state law. A risk exists that our lending and services could be deemed to be facilitating
the selling or distribution of cannabis in violation of the federal Controlled Substances Act, or to constitute aiding or abetting,
or being an accessory to, a violation of that Act. Such a finding, claim, or accusation would likely severely limit the Company’s
ability to continue with its operations and may result in our investors losing all of their investment in our Company.
The
legal cannabis industry faces an uncertain legal environment on state, federal, and local levels.
Although we continually monitor the most recent legal developments affecting
the legal cannabis industry, the legal environment in California and elsewhere could shift in a manner not currently contemplated
by the Company. For example, while we think there will always be a place for compliance-related services, broader state and federal
legalization could render the compliance landscape significantly less technical, which would render our suite of compliance services
less valuable and marketable. Lending money to legal cannabis participants could also be subject to legal challenge if the federal
government or another jurisdiction decides to more actively enforce applicable laws. These unknown legal developments could directly
and indirectly harm our business and results of operations.
Profit
sharing, distributions, and equity ownership in California medical marijuana dispensaries and growing operations are not permissible.
The Company does not currently maintain an ownership interest in legal cannabis dispensaries or
growing operations in California or elsewhere. We believe such ownership is not permitted by applicable law. Investors should
be aware that the Company will not engage in such activity until such time as it is legally permissible. If the applicable laws
make it so that the Company is unable to own interests in legal cannabis dispensaries in growing operations ever, the Company
may not be able to attain its financial projections, and thus, this would directly and indirectly harm our business and results
of operations.
We
depend on third party providers for a reliable Internet infrastructure and the failure of these third parties, or the Internet
in general, for any reason would significantly impair our ability to conduct our business.
We
outsource all of our data center facility management to third parties who host the actual servers and provide power and security
in multiple data centers in each geographic location. These third party facilities require uninterrupted access to the Internet.
If the operation of our servers is interrupted for any reason, including natural disaster, financial insolvency of a third party
provider, or malicious electronic intrusion into the data center, our business would be significantly damaged. If either a third
party facility failed, or our ability to access the Internet was interfered with because of the failure of Internet equipment
in general or we become subject to malicious attacks of computer intruders, our business and operating results will be materially
adversely affected.
The
gathering, transmission, storage and sharing or use of personal information could give rise to liabilities or additional costs
of operation as a result of governmental regulation, legal requirements, civil actions or differing views of personal privacy
rights.
We
transmit and plan to store a large volume of personal information in the course of providing our services. Federal and state laws
and regulations govern the collection, use, retention, sharing and security of data that we receive from our customers and their
users. Any failure, or perceived failure, by us to comply with U.S. federal or state privacy or consumer protection-related laws,
regulations or industry self-regulatory principles could result in proceedings or actions against us by governmental entities
or others, which could potentially have an adverse effect on our business, operating results and financial condition. Additionally,
we may also be contractually liable to indemnify and hold harmless our customers from the costs or consequences of inadvertent
or unauthorized disclosure of their customers’ personal data which we store or handle as part of providing our services.
The
interpretation and application of privacy, data protection and data retention laws and regulations are currently unsettled particularly
with regard to location-based services, use of customer data to target advertisements and communication with consumers via mobile
devices. Such laws may be interpreted and applied inconsistently from country to country and inconsistently with our current data
protection policies and practices. Complying with these varying international requirements could cause us to incur substantial
costs or require us to change our business practices in a manner adverse to our business, operating results or financial condition.
As
privacy and data protection have become more sensitive issues, we may also become exposed to potential liabilities as a result
of differing views on the privacy of personal information. These and other privacy concerns, including security breaches, could
adversely impact our business, operating results and financial condition.
In
the U.S., we have voluntarily agreed to comply with wireless carrier technological and other requirements for access to their
customers’ mobile devices, and also trade association guidelines and codes of conduct addressing the provision of location-based
services, delivery of promotional content to mobile devices and tracking of users or devices for the purpose of delivering targeted
advertising. We could be adversely affected by changes to these requirements, guidelines and codes, including in ways that are
inconsistent with our practices or in conflict with the rules or guidelines in other jurisdictions.
We
have identified material weaknesses in our internal control over financial reporting which could, if not remediated, result in
material misstatements in our financial statements.
Our
management is responsible for establishing and maintaining adequate internal control over our financial reporting, as defined
in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). A material weakness
is defined as a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a
reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected
on a timely basis. During the fourth quarter of fiscal year 2017, management identified material weaknesses in our internal control
over financial reporting as discussed in Item 9A of this Annual Report on Form 10-K. As a result of these material weaknesses,
our management concluded that our internal control over financial reporting was not effective based on criteria set forth by the
Committee of Sponsoring Organization of the Treadway Commission in Internal Control-An Integrated Framework. We are planning to
engage in developing a remediation plan designed to address these material weaknesses. If our remedial measures are insufficient
to address the material weaknesses, or if additional material weaknesses or significant deficiencies in our internal control are
discovered or occur in the future, our consolidated financial statements may contain material misstatements and we could be required
to restate our financial results, which could lead to substantial additional costs for accounting and legal fees and shareholder
litigation.
We
may require additional capital in the future, which may not be available or may only be available on unfavorable terms.
We
monitor our capital adequacy on an ongoing basis. To the extent that our funds are insufficient to fund future operating requirements,
we may need to raise additional funds through corporate finance transactions or curtail our growth and reduce our liabilities.
Any equity, hybrid or debt financing, if available at all, may be on terms that are not favorable to us. If we cannot obtain adequate
capital on favorable terms or at all, our business, financial condition and operating results could be adversely affected.
Risks
Relating to Ownership of Our Common Stock
Although
there is presently a market for our common stock, the price of our common stock may be extremely volatile and investors may not
be able to sell their shares at or above their purchase price, or at all. We anticipate that the market may be potentially highly
volatile and may fluctuate substantially because of:
|
•
|
Actual or anticipated fluctuations in our future
business and operating results;
|
|
•
|
Changes in or failure to meet market expectations;
|
|
•
|
Fluctuations in stock market price and volume
|
Our
Chief Executive Officer, B. Michael Friedman, holds Series B Preferred Stock which will provide him continuing voting control
over the Company and, as a result, he will exercise significant control over corporate decisions.
B.
Michael Friedman, our President, Chief Executive Office and sole Director owns 100% of Class B Preferred Stock (the “Series
B Preferred Stock”). Pursuant to the Certificate of Designation, the Series B
P
ref
e
r
red
S
tock has the right to vote in aggregate, on all shareholder matters equal to 51%
of the total vote, no matter how many shares of common stock or other voting stock of the Company are issued or outstanding in
the future. The Series B Preferred Stock has a right to vote on all matters presented or submitted to the Company’s stockholders
for approval in pari passu with the common stockholders, and not as a separate class. The holders of Series B Preferred Stock
have the right to cast votes for each share of Series B Preferred Stock held of record on all matters submitted to a vote of common
stockholders, including the election of directors. There is no right to cumulative voting in the election of directors. The holders
of Series B Preferred Stock vote together with all other classes and series of common stock of the Company as a single class on
all actions to be taken by the common stockholders except to the extent that voting as a separate class or series is required
by law.
As
a result of the above, Mr. Friedman exercises control in determining the outcome of corporate transactions or other matters, including
the election of directors, mergers, consolidations, the sale of all or substantially all of our assets, and also the power to
prevent or cause a change in control. Any investors who purchase shares will be minority shareholders and as such will have no
say in the direction of the Company and the election of Directors. Investors in the Company should keep in mind that even if you
own shares of the Company's common stock and wish to vote them at annual or special shareholder meetings, your shares will have
no effect on the outcome of corporate decisions or the election of Directors. Furthermore, investors should be aware that Mr.
Friedman may choose to elect new Directors to the Board of Directors of the Company and/or take the Company in a new business
direction altogether, and, as a result, current shareholders of the Company will have little to no say in such matters.
As
a public company, we will incur substantial expenses.
The
U.S. securities laws require, among other things, review, audit, and public reporting of our financial results, business activities,
and other matters. Recent SEC regulation, including regulation enacted as a result of the Sarbanes-Oxley Act of 2002, has also
substantially increased the accounting, legal, and other costs related to becoming and remaining an SEC reporting company. If
we do not have current information about our Company available to market makers, they will not be able to trade our stock. The
public company costs of preparing and filing annual and quarterly reports, and other information with the SEC and furnishing audited
reports to stockholders, will cause our expenses to be higher than they would be if we were privately-held. These increased costs
may be material and may include the hiring of additional employees and/or the retention of additional advisors and professionals.
Our failure to comply with the federal securities laws could result in private or governmental legal action against us and/or
our officers and directors, which could have a detrimental effect on our business and finances, the value of our stock, and the
ability of stockholders to resell their stock.
FINRA
sales practice requirements may limit a stockholder’s ability to buy and sell our stock.
“FINRA”
has adopted rules that relate to the application of the SEC’s penny stock rules in trading our securities and require that
a broker/dealer have reasonable grounds for believing that the investment is suitable for that customer, prior to recommending
the investment. Prior to recommending speculative, low priced securities to their non-institutional customers, broker/dealers
must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives
and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative,
low priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker/dealers
to recommend that their customers buy our common stock, which may have the effect of reducing the level of trading activity and
liquidity of our common stock. Further, many brokers charge higher transactional fees for penny stock transactions. As a result,
fewer broker/dealers may be willing to make a market in our common stock, reducing a shareholder’s ability to resell shares
of our common stock.
The
Company’s common stock is currently deemed to be “penny stock”, which makes it more difficult for investors
to sell their shares
.
The
Company’s common stock is currently subject to the “penny stock” rules adopted under section 15(g) of the Exchange
Act. The penny stock rules apply to companies whose common stock is not listed on the NASDAQ Stock Market or other national securities
exchange and trades at less than $5.00 per share or that have tangible net worth of less than $5,000,000 ($2,000,000 if the company
has been operating for three or more years). These rules require, among other things, that brokers who trade penny stock to persons
other than “established customers” complete certain documentation, make suitability inquiries of investors and provide
investors with certain information concerning trading in the security, including a risk disclosure document and quote information
under certain circumstances. Many brokers have decided not to trade penny stocks because of the requirements of the penny stock
rules and, as a result, the number of broker-dealers willing to act as market makers in such securities is limited. If the Company
remains subject to the penny stock rules for any significant period, it could have an adverse effect on the market, if any, for
the Company’s securities. If the Company’s securities are subject to the penny stock rules, investors will find it
more difficult to dispose of the Company’s securities.
We
have raised capital through the use of convertible debt instruments that causes substantial dilution to our stockholders.
Because
of the size of our Company and its status as a “penny stock” as well as the current economy and difficulties in companies
our size finding adequate sources of funding, we have been forced to raise capital through the issuance of convertible notes and
other debt instruments. These debt instruments carry favorable conversion terms to their holders of up to 42% discounts to the
market price of our common stock on conversion and in some cases provide for the immediate sale of our securities into the open
market. Accordingly, this has caused dilution to our stockholders in 2017 and may for the foreseeable future. As of December 31,
2017, we had approximately $979,443 in convertible debt and potential convertible debt outstanding. This convertible debt balance
as well as additional convertible debt we incur in the future will cause substantial dilution to our stockholders.
Because
we are quoted on the OTCQB instead of an exchange or national quotation system, our investors may have a tougher time selling
their stock or experience negative volatility on the market price of our common stock.
Our
common stock is quoted on the OTCQB. The OTCQB is often highly illiquid, in part because it does not have a national quotation
system by which potential investors can follow the market price of shares except through information received and generated by
a limited number of broker-dealers that make markets in particular stocks. There is a greater chance of volatility for securities
that are quoted on the OTCQB as compared to a national exchange or quotation system. This volatility may be caused by a variety
of factors, including the lack of readily available price quotations, the absence of consistent administrative supervision of
bid and ask quotations, lower trading volume, and market conditions. Investors in our common stock may experience high fluctuations
in the market price and volume of the trading market for our securities. These fluctuations, when they occur, have a negative
effect on the market price for our securities. Accordingly, our stockholders may not be able to realize a fair price from their
shares when they determine to sell them or may have to hold them for a substantial period of time until the market for our common
stock improves.
We
do not intend to pay dividends.
We
do not anticipate paying cash dividends on our common stock in the foreseeable future. We may not have sufficient funds to legally
pay dividends. Even if funds are legally available to pay dividends, we may nevertheless decide in our sole discretion not to
pay dividends. The declaration, payment and amount of any future dividends will be made at the discretion of the board of directors,
and will depend upon, among other things, the results of our operations, cash flows and financial condition, operating and capital
requirements, and other factors our board of directors may consider relevant. There is no assurance that we will pay any dividends
in the future, and, if dividends are paid, there is no assurance with respect to the amount of any such dividend.
Our
operating history and lack of profits which could lead to wide fluctuations in our share price. You may be unable to sell your
common shares at or above your purchase price, which may result in substantial losses to you. The market price for our common
shares is particularly volatile given our status as a relatively unknown company with a small and thinly traded public float.
The
market for our common shares is characterized by significant price volatility when compared to seasoned issuers, and we expect
that our share price will continue to be more volatile than a seasoned issuer for the indefinite future. The volatility in our
share price is attributable to a number of factors. First, our common shares are sporadically and thinly traded. As a consequence
of this lack of liquidity, the trading of relatively small quantities of shares by our shareholders may disproportionately influence
the price of those shares in either direction. The price for our shares could, for example, decline precipitously in the event
that a large number of our common shares are sold on the market without commensurate demand, as compared to a seasoned issuer
which could better absorb those sales without adverse impact on its share price. Secondly, we are a speculative or “risky”
investment due to our limited operating history and lack of profits to date, and uncertainty of future market acceptance for our
potential products. As a consequence of this enhanced risk, more risk-adverse investors may, under the fear of losing all or most
of their investment in the event of negative news or lack of progress, be more inclined to sell their shares on the market more
quickly and at greater discounts than would be the case with the stock of a seasoned issuer. Many of these factors are beyond
our control and may decrease the market price of our common shares, regardless of our operating performance. We cannot make any
predictions or projections as to what the prevailing market price for our common shares will be at any time, including as to whether
our common shares will sustain their current market prices, or as to what effect that the sale of shares or the availability of
common shares for sale at any time will have on the prevailing market price.
Shareholders
should be aware that, according to SEC Release No. 34-29093, the market for penny stocks has suffered in recent years from patterns
of fraud and abuse. Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often
related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and
misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by
inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5)
the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level,
along with the resulting inevitable collapse of those prices and with consequent investor losses. Our management is aware of the
abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate the
behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical
limitations to prevent the described patterns from being established with respect to our securities. The occurrence of these patterns
or practices could increase the volatility of our share price.
Federal
regulation and enforcement may adversely affect the implementation of marijuana laws and regulations may negatively impact our
revenues and profits
.
Currently,
there are thirty states plus the District of Columbia that have laws and/or regulation that recognize in one form or another legitimate
medical uses for cannabis and consumer use of cannabis in connection with medical treatment. There are currently two states that
have laws and/or regulation that permits consumer use of cannabis for commercial and recreational purposes. Many other states
are considering legislation to similar effect. As of the date of this writing, the policy and regulations of the Federal government
and its agencies is that cannabis has no medical benefit and a range of activities including cultivation and use of cannabis for
personal use is prohibited on the basis of federal law and may or may not be permitted on the basis of state law. Active enforcement
of the current federal regulatory position on cannabis on a regional or national basis may directly and adversely affect the willingness
of customers of the Company to invest in or lease properties from the Company that may be used in connection with cannabis. Active
enforcement of the current federal regulatory position on cannabis may thus indirectly and adversely affect revenues and profits
of the Company.
We
may be subject to unknown or contingent liabilities or restrictions related to properties that we acquire for which we may have
limited or no recourse.
Assets
and entities that we have acquired or may acquire in the future may be subject to unknown or contingent liabilities for which
we may have limited or no recourse against the sellers. Unknown or contingent liabilities might include liabilities for or with
respect to liens attached to properties, unpaid real estate tax, or utilities charges for which a subsequent owner remains liable,
clean-up or remediation of environmental conditions or code violations, claims of customers, vendors or other persons dealing
with the acquired entities and tax liabilities, among other things.
Our
revenue and expenses are not directly correlated, and because a large percentage of our costs and expenses are fixed, we may not
be able to adapt our cost structure to offset declines in our revenue.
Most
of the expenses associated with our business, such as acquisition costs, renovation and maintenance costs, real estate taxes,
personal and ad valorem taxes, insurance, utilities, employee wages and benefits and other general corporate expenses are fixed
and do not necessarily decrease with a reduction in revenue from our business. Our expenses and ongoing capital expenditures will
also be affected by inflationary increases and certain of our cost increases may exceed the rate of inflation in any given period.
By contrast, as described above, our rental income will be affected by many factors beyond our control such as the availability
of alternative rental properties and economic conditions in our target markets. As a result, we may not be able to fully offset
rising costs and capital spending by higher lease rates, which could have a material adverse effect on our results of operations
and cash available for distribution. In addition, state and local regulations may require us to maintain properties that we own,
even if the cost of maintenance is greater than the value of the property or any potential benefit from leasing the property.
Our
future portfolio consists of properties geographically concentrated in certain markets and any adverse developments in local economic
conditions, the demand for commercial property in these markets or natural disasters may negatively affect our operating results.
Our
future portfolio consists of properties geographically concentrated in Colorado. As such, we are susceptible to local economic
conditions, other regulations, the supply of and demand for commercial rental properties and natural disasters in these areas.
If there is a downturn in the economy, an oversupply of or decrease in demand for commercial rental properties in these markets
or natural disasters in these geographical areas, our business could be materially adversely affected to a greater extent than
if we owned a real estate portfolio that was more geographically diversified.
We
may be subject to losses that are either uninsurable, not economically insurable or that are in excess of our insurance coverage.
Our
properties may be subject to environmental liabilities and we will be exposed to personal liability for accidents which may occur
on our properties. Our insurance may not be adequate to cover all damages or losses from these events, or it may not be economically
prudent to purchase insurance for certain types of losses. As a result, we may be required to incur significant costs in the event
of adverse weather conditions and natural disasters or events which result in environmental or personal liability. We may not
carry or may discontinue certain types of insurance coverage on some or all of our properties in the future if the cost of premiums
for any of these policies in our judgment exceeds the value of the coverage discounted for the risk of loss. If we experience
losses that are uninsured or exceed policy limits, we could incur significant uninsured costs or liabilities, lose the capital
invested in the properties, and lose the anticipated future cash flows from those properties. In addition, our environmental or
personal liability may result in losses substantially in excess of the value of the related property.
Compliance
with new or existing laws, regulations and covenants that are applicable to our future properties, including permit, license and
zoning requirements, may adversely affect our ability to make future acquisitions or renovations, result in significant costs
or delays and adversely affect our growth strategy.
Our
future properties are subject to various covenants and local laws and regulatory requirements, including permitting and licensing
requirements. Local regulations, including municipal or local ordinances, zoning restrictions and restrictive covenants imposed
by community developers may restrict our use of our properties and may require us to obtain approval from local officials or community
standards organizations at any time with respect to our properties, including prior to acquiring a property or when undertaking
renovations of any of our existing properties. We cannot assure you that existing regulatory policies will not adversely affect
us or the timing or cost of any future acquisitions or renovations, or that additional regulations will not be adopted that would
increase such delays or result in additional costs. Our failure to obtain permits, licenses and zoning approvals on a timely basis
could have a material adverse effect on our business, financial condition and results of operations.
Poor
tenant selection and defaults by renters may negatively affect our financial performance and reputation.
Our
success will depend in large part upon our ability to attract and retain qualified tenants for our properties. This will depend,
in turn, upon our ability to screen applicants, identify good tenants and avoid tenants who may default. We will inevitably make
mistakes in our selection of tenants, and we may rent to tenants whose default on our leases or failure to comply with the terms
of the lease negatively affect our financial performance, reputation and the quality and value of our properties. For example,
tenants may default on payment of rent, make unreasonable and repeated demands for service or improvements, make unsupported or
unjustified complaints to regulatory or political authorities, make use of our properties for illegal purposes, damage or make
unauthorized structural changes to our properties which may not be fully covered by security deposits, refuse to leave the property
when the lease is terminated, engage in violence or similar disturbances, disturb nearby residents with noise, trash, odors or
eyesores, fail to comply with regulations, sublet to less desirable individuals in violation of our leases, or permit unauthorized
persons to live therein. The process of evicting a defaulting renter from a commercial property can be adversarial, protracted
and costly. Furthermore, some tenants facing eviction may damage or destroy the property. Damage to our properties may significantly
delay re-leasing after eviction, necessitate expensive repairs or impair the rental income or value of the property, resulting
in a lower than expected rate of return. In addition, we will incur turnover costs associated with re-leasing the properties such
as marketing and brokerage commissions and will not collect revenue while the property sits vacant. Although we will attempt to
work with tenants to prevent such damage or destruction, there can be no assurance that we will be successful in all or most cases.
Such tenants will not only cause us not to achieve our financial objectives for the properties, but may subject us to liability,
and may damage our reputation with our other tenants and in the communities where we do business.
Declining
real estate valuations and impairment charges could adversely affect our earnings and financial condition.
Our
success will depend upon our ability to acquire rental properties at attractive valuations, such that we can earn a satisfactory
return on the investment primarily through rental income and secondarily through increases in the value of the properties. If
we overpay for properties or if their value subsequently drops or fails to rise because of market factors, we will not achieve
our financial objectives.
We
will periodically review the value of our properties to determine whether their value, based on market factors, projected income
and generally accepted accounting principles, has permanently decreased such that it is necessary or appropriate to take an impairment
loss in the relevant accounting period. Such a loss would cause an immediate reduction of net income in the applicable accounting
period and would be reflected in a decrease in our balance sheet assets. The reduction of net income from an impairment loss could
lead to a reduction in our dividends, both in the relevant accounting period and in future periods. Even if we do not determine
that it is necessary or appropriate to record an impairment loss, a reduction in the intrinsic value of a property would become
manifest over time through reduced income from the property and would therefore affect our earnings and financial condition.
Increasing
real estate taxes, fees and insurance costs may negatively impact our financial results.
The
cost of real estate taxes and insuring our properties is a significant component of our expenses. Real estate taxes, fees and
insurance premiums are subject to significant increases, which can be outside of our control. If the costs associated with real
estate taxes, fees and assessments or insurance should rise significantly and we are unable to raise rents to offset such increases,
our results of operations would be negatively impacted.
We
may not be able to effectively manage our growth, which requires significant resources, and our results may be adversely affected.
We
plan to continue our acquisition strategy, which will demand significant resources and attention and may affect our financial
performance. Our future operating results depend on our ability to effectively manage this growth, which is dependent, in part,
upon the ability of the Company to:
•
|
stabilize and manage a rapidly increasing
number of properties and tenant relationships while maintaining a high level of customer service and building and enhancing
our brand;
|
•
|
identify and supervise an increasing number of
suitable third parties on which we rely on to provide certain services to our properties;
|
•
|
continue to improve our operational and financial
controls and reporting procedures and systems; and,
|
•
|
scale our technology and
other infrastructure platforms to adequately service new properties.
|
We
cannot assure you that we will be able to achieve these results or that we may otherwise be able to manage our growth effectively.
Any failure to do so may have an adverse effect on our business and financial results.
Should
one or more of the foregoing risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual
results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.
ITEM
1B. UNRESOLVED STAFF COMMENTS
Not
applicable to a smaller reporting company.
ITEM
2. DESCRIPTION OF PROPERTY
Owned
Real Estate
The
Company owns approximately 80 acres real property, including all buildings, fixtures and equipment located in Pueblo County, Colorado.
The Company acquired the property for the purpose of making it suitable for use in the legal commercial cannabis industry.
Office
Space
Our
corporate offices are located at 777 Brickell Avenue Suite 500, Miami, FL 33131. We can be reached by phone at 1 (305) 721-2727
and by email at info@Agritekholdings.com
Leased
Properties
On
April 28, 2014, the Company executed and closed a 10 year lease agreement for 20 acres of an agricultural farming facility located
in South Florida following the approval of the so-called “Charlotte’s Web” legislation, aimed at decriminalizing
low grade marijuana specifically for the use of treating epilepsy and cancer patients. The Company prepaid the first-year
lease amount of $24,000.
The Company is currently in default of the lease agreement, as
rents have not been for the second year of the lease beginning May 2015.
On
July 11, 2014, the Company signed a ten year
lease agreement for an additional 40 acres
in Pueblo, Colorado. The lease requires monthly rent payments of $10,000 during the first year and is subject to a 2% annual increase
over the life of the lease. The lease also provides rights to 50 acres of certain tenant water rights for $50,000 annually plus
cost of approximately $2,400 annually. The Company paid the $50,000 in July 2014. The Company is currently in default of the lease
agreement, as rents have not been paid since February 2015.
In
January 2017, the Company signed a five (5) year lease, beginning February 1, 2107, for approximately 6,000 square feet of office
space, comprised of two floors, in San Juan, Puerto Rico. Pursuant to the lease, the Company will pay $3,000 per month for the
third floor of the building for the first year of the lease. The rent will increase 3% per year on February beginning in 2018
and an additional 3% per year on each successive February 1, during the term of the lease. The landlord has agreed that for the
month of February 2017, the rent will be $1,500. The rent for second floor of the building will be $2,000 per month during the
term of the lease and the Company does not have any rent payments for the first three months of the lease (February 2017 through
April 2017). Through September 30, 2017, the Company calculated the total amount of the rent for the term lease and recorded straight
line rent expense of $45,417 and had made payments of $20,516. As of December 31, 2017, the Company has a balance of $24,916 in
deferred rent which is included in the consolidated balance sheet. The leases for the second and third floor were cancelled in
September 2017, as a result of Hurricane Irma.
On
December 1, 2016, the Company signed a one (1) year lease for a corporate apartment in Puerto Rico for $5,500 per month. This
lease expired in November 30, 2017.
ITEM
3. LEGAL PROCEEDINGS.
On
March 2, 2015, the Company, the Company’s CEO and the Company’s CFO at the time were named in a civil
complaint filed by Erick Rodriguez in the District Court in Clark County, Nevada (the “DCCC”). The complaint
alleges that Mr. Rodriguez never received 250,000 shares of Series B preferred stock that were initially approved by the
Board of Directors in 2012, subject to the completion of a merger of a company controlled by Mr. Rodriguez. Since the merger
was never completed, the shares were never certificated to Mr. Rodriguez. On March 21, 2017, the DCC agreed to Set Aside the
Entry of Default against the Defendants. Mr. Rodriguez resigned in June 2013. On April 12, 2018, the Arbitrator issued a
final award to Rodriguez in the amount of $399,291. The Company and the Company’s counsel believe the Arbitrator denied
a number of detailed objections to the award, which cited clear mistakes as to Nevada law and to the facts. The Company has
retained a Nevada attorney who is an expert in fighting attempts to convert arbitration awards into judgments in Nevada
courts, to work with our arbitration counsel. The Company recorded a loss on legal matter, included in other expenses for the
year ended December 31, 2017.
On
May 6, 2016, the Company, B. Michael Freidman and Barry Hollander (former CFO) were named as defendants in a Summons/Complaint
filed by Justin Braune (the “Plaintiff”) in Palm Beach County Civil Court, Florida (the “PBCCC”). The
complaint alleges that Mr. Braune was entitled to shares of common stock of the Company. On December 5, 2016, the PBCCC set aside
a court default that had been previously issued. The defendants have answered the complaint, including the defenses that Mr. Braune
advised the Company’s transfer agent and the Company in his letter of resignation dated November 4, 2015, clearly stating
that he has relinquished all shares of common stock. The Company has filed a counterclaim suit against the Plaintiff, as well
as sanctions against the Plaintiff and their counsel.
ITEM
4. MINE SAFETY DISCLOSURES
Not
applicable.
Notes to Consolidated
Financial Statements
December 31,
2017 and 2016
Note 1 -
Organization
Business
Agritek
Holdings Inc. (“the Company” or “Agritek Holdings”)
and its wholly-owned
subsidiaries, MediSwipe, Inc. (“MediSwipe”), Prohibition Products Inc., and Agritek Venture Holdings, Inc. (“AVHI”)
is a fully integrated, active investor and operator in the legal cannabis sector. Specifically,
Agritek Holdings provides strategic capital and functional expertise to accelerate the commercialization of its diversified portfolio
of holdings. Currently, the Company is focused on three high-value segments of the cannabis market, including real estate investment,
intellectual property brands; and infrastructure, with operations in three U.S. States, Colorado, Washington State, California
as well as Canada and Puerto Rico. Agritek Holdings invests its capital via real estate holdings, licensing agreements, royalties
and equity in acquisition operations.
We
provide key business services to the legal cannabis sector including:
|
•
|
Funding and Financing Solutions for
Agricultural Land and Properties zoned for the regulated Cannabis Industry.
|
|
•
|
Dispensary and Retail Solutions
|
|
•
|
Commercial Production and Equipment Build Out
Solutions
|
|
•
|
Multichannel Supply Chain Solutions
|
|
•
|
Branding, Marketing and Sales Solutions of proprietary
product lines
|
|
•
|
Consumer Product Solutions
|
The
Company intends to bring its’ array of services to each new state that legalizes the use of cannabis according to appropriate
state and federal laws. Our primary objective is acquiring commercial properties to be utilized in the commercial marijuana industry
as cultivation facilities in compliance with state laws. This is an essential aspect of our overall growth strategy because once
acquired and re-zoned, the value of such real property is substantially higher than under the previous zoning and use.
Once
properties are identified and acquired to be used for purposes related to the commercial marijuana industry as provided for by
state law, and we plan to create vertical channels within that legal jurisdiction including equipment financing, payment processing
and marketing of exclusive brands and services to retail dispensaries.
Agritek’s
business focus is primarily to hold, develop and manage real property. The Company shall also provide oversight on every property
that is part of its portfolio. This can include complete architectural design and subsequent build-outs, general support, landscaping,
general up-keep, and state of the art security systems. At this time, Agritek does not grow, process, own, handle, transport,
or sell marijuana as the Company is organized and directed to operate strictly in accordance with all applicable state and federal
laws. As the legal environment changes in Colorado, California and other states, the Company’s management may explore business
opportunities that involve ownership interests in dispensaries and growing operations if and when such business opportunities
become legally permissible under applicable state and federal laws.
Note 2 –
Summary of Significant Accounting Policies
Basis of
Presentation and Principles of Consolidation
The accompanying
consolidated financial statements are prepared in accordance with Generally Accepted Accounting Principles in the United States
of America ("US GAAP"). The consolidated financial statements of the Company
include
the consolidated accounts of Agritek and its’ wholly owned subsidiaries MediSwipe, AVHI, The American Hemp Trading Company,
Inc., a Colorado Corporation (dba 77Acres, Inc.) and PPI. PPI, a Florida corporation, was originally formed on July 1, 2013 as
The American Hemp Trading Company, Inc. (“HempFL”) and on August 27, 2014, HempFL changed its’ name to PPI.
All intercompany accounts and transactions have been eliminated in consolidation.
Cash and
Cash Equivalents
The Company considers
all highly liquid investments with an original term of three months or less to be cash equivalents.
Accounts
Receivable
The Company records
accounts receivable from amounts due from its customers upon the shipment of products. The allowance for losses is established
through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes
collectability is unlikely. The allowance is an amount that management believes will be adequate to absorb estimated losses on
existing receivables, based on evaluation of the collectability of the accounts and prior loss experience. While management uses
the best information available to make its evaluations, this estimate is susceptible to significant change in the near term. As
of December 31, 2017 and 2016, based on the above criteria, the Company has a full allowance for doubtful accounts of $43,408.
Inventory
Inventory is valued
at the lower of cost or market value. Cost is determined using the first in first out (FIFO) method. Provision for pot
entially
obsolete or slow-moving inventory is made based on management analysis or inventory levels and future sales forecasts.
Notes
receivable
During
the year ended December 31, 2017, the Company has recorded notes receivable the following:
|
•
|
$110,000
pursuant to a five (5) year operational and exclusive licensing agreement with a third
party who leases a 25,000-sq. ft. approved cultivation facility located in San Juan,
Puerto Rico (see Note 10).
|
|
•
|
$100,000
pursuant to a five (5) year operational and exclusive licensing agreement with a third
party who leases a 10,000-sq. ft. approved cultivation facility located in Washington
State (see Note 10).
|
Deferred
Financing Costs
The
costs related to the issuance of debt are capitalized and amortized to interest expense using the straight-line method through
the maturities of the related debt.
Derivative
Financial Instruments
The Company does
not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of
it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features
that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative
instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value
reported as charges or credits to income.
For option-based
simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments
at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
Debt Issue
Costs and Debt Discount
The Company may
record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be
paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt.
If a conversion of the underlying debt occurs prior to maturity a proportionate share of the unamortized amounts is immediately
expensed.
Original
Issue Discount
For certain convertible
debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded
to debt discount, reducing the initial carrying value of the note and is amortized to interest expense through the maturity of
the debt. If a conversion of the underlying debt occurs prior to maturity a proportionate share of the unamortized amounts
is immediately expensed.
Marketable
Securities and Other Comprehensive Income
The Company classifies
its marketable securities as available-for-sale securities, which are carried at their fair value based on the quoted market prices
of the securities with unrealized gains and losses, net of deferred income taxes, reported as accumulated other comprehensive
income (loss), a separate component of stockholders’ equity. Realized gains and losses on available-for-sale securities
are included in net earnings in the period earned or incurred.
Investment
of Non-Marketable Securities
In 2014,
the Company purchased an investment in non-marketable securities of a less than 10% interest in two privately held companies of
$25,000 each, that provide merchant processing services. During the year ended December 31, 2017, due to recent losses, management
wrote off the investment of $50,000, which is included in Other expenses on the consolidated statements of operations included
herein. As of December 31, 2017, and 2016, the balance of the Investment of Non-Marketable Securities and Other was $-0- and $50,000,
respectively
Property
and Equipment
Property and
equipment are stated at cost, and except for land, depreciation is provided by use of a straight-line method over the
estimated useful lives of the assets. The Company reviews property and equipment for potential impairment whenever events or
changes in circumstances indicate that the carrying amounts of assets may not be recoverable. In February, 2017, the Company
entered into a land purchase contract to acquire approximately 80 acres including water and mineral rights. The total cost of
the land was $129,555. The Company paid $41,554 at closing and issued a note payable for $88,000. As of December 31, 2017,
the Company is on the deed of trust of the property with a remaining note balance of $51,500 due the seller. The estimated
useful lives of property and equipment are as follows:
Furniture and equipment
|
5 years
|
Manufacturing equipment
|
7 years
|
The Company's property
and equipment consisted of the following at December 31, 2017, and 2016:
|
|
December
31,
2017
|
|
December
31,
2016
|
Furniture and equipment
|
|
$
|
180,684
|
|
|
$
|
34,587
|
|
Land
|
|
|
129,555
|
|
|
|
—
|
|
Accumulated
depreciation
|
|
|
(23,824
|
)
|
|
|
(8,307
|
)
|
Balance
|
|
$
|
286,415
|
|
|
$
|
26,280
|
|
Depreciation expense
of $15,516 and $3,566 was recorded for the years ended December 31, 2017, and 2016, respectively.
Long-Lived
Assets
Long-lived assets
are reviewed for impairment when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Deferred
rent
The
Company calculates the total cost of the lease for the entire lease period and divides that amount by the number of months of
the lease. The result is the average monthly expense and is charged to rent expense with the offset to deferred rent, irrespective
of the actual amount paid. The amounts paid are charged to the deferred rent account.
Rent
expense of $45,417 for the year ended December 31, 2017, was recorded for the office space in Puerto Rico and the Company made
payments of $20,516. As of December 31, 2017, the Company has a balance of $24,916 in deferred rent which is included in the consolidated
balance sheet.
Revenue Recognition
The Company recognizes
revenue in accordance with FASB ASC 605, Revenue Recognition. ASC 605 requires that four basic criteria are met: (1) persuasive
evidence of an arrangement exists, (2) delivery of products and services has occurred, (3) the fee is fixed or determinable and
(4) collectability is reasonably assured. The Company recognizes revenue during the month in which products are shipped or fees
are earned. Consulting revenue of $48,000 and product sales (net) of $2,000 has been recognized for the year ended December 31,
2017.
Fair Value
of Financial Instruments
The Company measures
assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements,
which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be,
in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants
would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework
for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned
a hierarchical level.
The following are
the hierarchical levels of inputs to measure fair value:
|
☐
|
Level 1 - Observable inputs that reflect quoted market
prices in active markets for identical assets or liabilities.
|
|
☐
|
Level 2 - Inputs reflect quoted
prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities
in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived
principally from or corroborated by observable market data by correlation or other means.
|
|
☐
|
Level 3 - Unobservable inputs
reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions
are required to be consistent with market participant assumptions that are reasonably available.
|
The carrying amounts
of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and
accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short
maturity of these instruments.
The following table
represents the Company’s financial instruments that are measured at fair value on a recurring basis as of December 31, 2017,
and 2016, for each fair value hierarchy level:
December
31, 2017
|
|
Derivative
Liabilities
|
|
Total
|
Level
I
|
|
$
|
—
|
|
|
$
|
—
|
|
Level
II
|
|
$
|
—
|
|
|
$
|
—
|
|
Level
III
|
|
$
|
5,416,830
|
|
|
$
|
5,416,830
|
|
December
31, 2016
|
|
|
|
|
|
|
|
|
Level
I
|
|
$
|
—
|
|
|
$
|
—
|
|
Level
II
|
|
$
|
—
|
|
|
$
|
—
|
|
Level
III
|
|
$
|
1,613,770
|
|
|
$
|
1,613,770
|
|
Income Taxes
The Company accounts
for income taxes in accordance with ASC 740-10, Income Taxes. Deferred tax assets and liabilities are recognized to reflect the
estimated future tax effects, calculated at the tax rate expected to be in effect at the time of realization. A valuation allowance
related to a deferred tax asset is recorded when it is more likely than not that some portion of the deferred tax asset will not
be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date
of enactment.
ASC 740-10 prescribes
a recognition threshold that a tax position is required to meet before being recognized in the financial statements and provides
guidance on recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition
issues. Interest and penalties are classified as a component of interest and other expenses. To date, the Company has not been
assessed, nor paid, any interest or penalties.
Uncertain tax positions
are measured and recorded by establishing a threshold for the financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. Only tax positions meeting the more-likely-than-not recognition threshold at the
effective date may be recognized or continue to be recognized. The Company’s tax years subsequent to 2005 remain subject
to examination by federal and state tax jurisdictions.
Earnings
(Loss) Per Share
Earnings (loss)
per share are computed in accordance with ASC 260, "Earnings per Share". Basic earnings (loss) per share is computed
by dividing net income (loss), after deducting preferred stock dividends accumulated during the period, by the weighted-average
number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income
by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities,
if any, outstanding during the period. As of December 31, 2017, there were warrants and options to purchase 49,135,392 shares
of common stock and the Company’s outstanding convertible debt is convertible into approximately 138,041,561 shares of common
stock. These amounts are not included in the computation of dilutive loss per share because their impact is anti-dilutive.
Accounting
for Stock-Based Compensation
The Company
accounts for stock awards issued to non-employees in accordance with ASC 505-50, Equity-Based Payments to Non-Employees. The
measurement date is the earlier of (1) the date at which a commitment for performance by the counterparty to earn the equity
instruments is reached, or (2) the date at which the counterparty's performance is complete. Stock awards granted to
non-employees are valued at their respective measurement dates based on the trading price of the Company’s common stock
and recognized as expense during the period in which services are provided. For the year ended December 31, 2017, and 2016
the Company recorded stock- based compensation of $520,600 and $2,371, respectively (See Notes 10 and 11).
Use of Estimates
The preparation
of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of revenues
and expenses during the reported period. Actual results could differ from those estimates.
Advertising
The Company records
advertising costs as incurred. For the years ending December 31, 2017, and 2016, advertising expenses was $54,927 and $8,321,
respectively.
Note 3 –
Recent Accounting Pronouncements
In
February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2016-02, “Leases (Topic 842)”. Under this guidance, an entity is required to recognize right-of-use assets and
lease liabilities on its balance sheet and disclose key information about leasing arrangements. This guidance offers specific
accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative
and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing
and uncertainty of cash flows arising from leases. This guidance is effective for annual reporting periods beginning after December
15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption
permitted. The Company is currently evaluating the impact of the adoption of this standard will have on our consolidated financial
statements.
In
March 2016, the FASB issued ASU 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based
Payment Accounting”. The standard is intended to simplify several areas of accounting for share-based compensation arrangements,
including the income tax impact, classification on the statement of cash flows and forfeitures. ASU 2016-09 is effective for fiscal
years, and interim periods within those years, beginning after December 15, 2016, and early adoption is permitted. The Company
elected to early adopt the new guidance in the second quarter of fiscal year 2016 which requires us to reflect any adjustments
as of January 1, 2016, the beginning of the annual period that includes the interim period of adoption. The primary impact
of adoption was the recognition of additional stock compensation expense and paid-in capital for all periods in fiscal year 2016. Additional
amendments to the recognition of excess tax benefits, accounting for income taxes and minimum statutory withholding tax requirements
had no impact to retained earnings as of January 1, 2016, where the cumulative effect of these changes is required
to be recorded. We have elected to account for forfeitures as they occur to determine the amount of compensation cost to be recognized
in each period.
In
November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flows (Topic 230).” ASU No. 2016-18 requires that
restricted cash be included with cash and cash equivalents when reconciling the change in cash flow. This guidance is reflected
in these financial statements.
In
January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, which removes the second step of
the two-step goodwill impairment test. Under ASU 2017-04, an entity will apply a one-step quantitative test and record the amount
of goodwill impairment as the excess of a reporting unit’s carrying amount over its fair value, not to exceed the total
amount of goodwill allocated to the reporting unit. ASU 2017-04 does not amend the optional qualitative assessment of goodwill
impairment. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount
of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for annual or any interim
goodwill impairment tests in fiscal years beginning after December 15, 2019; early adoption is permitted for interim or annual
goodwill impairment tests performed on testing dates after January 1, 2017. The Company has not elected early adoption of this
standard and is currently in the process of evaluating the impact of adopting ASU 2017-04 and cannot currently estimate the financial
statement impact of adoption.
In
May 2017, the FASB issued ASU No. 2017-09, “Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting.”
The amendments in this update provide guidance about which changes to the terms or conditions of a share-based award require an
entity to apply modification accounting in Topic 718. The guidance will be effective for the Company for its fiscal year
2018, with early adoption permitted. The Company does not expect this ASU to materially impact the Company’s consolidated
financial statements.
Accounting
standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a
future date are not expected to have a material impact on the consolidated financial statements upon adoption.
Note 4 – Marketable Securities
The Company owns marketable securities
(common stock) as outlined below:
|
|
2017
|
|
2016
|
Balance January 1
|
|
$
|
39,769
|
|
|
$
|
—
|
|
Fair value of stock received
|
|
|
—
|
|
|
|
16,525
|
|
Unrealized gain marked to fair
value
|
|
|
2,093
|
|
|
|
23,244
|
|
Balance December 31
|
|
$
|
41,862
|
|
|
$
|
39,769
|
|
800 Commerce, Inc.
(now known as Petrogress, Inc), was a commonly controlled entity until February 29, 2016, owed Agritek $282,947 as of February
29, 2016, as a result of advances received from or payments made by Agritek on behalf of 800 Commerce. These advances were non-interest
bearing and were due on demand. Effective February 29, 2016, the Company received 1,102,462 shares of common stock of Petrogress,
Inc. as settlement of the $282,947 owed to the Company. The market value on the date the Company received the shares of common
stock was $16,525.
Note 5 - Prepaid Expenses
Prepaid expenses consisted of the following
at December 31, 2017 and December 31, 2016:
|
|
December
31, 2017
|
|
December
31, 2016
|
|
|
|
|
|
Vendor deposits
|
|
$
|
46,000
|
|
|
$
|
6,000
|
|
Consulting fees
|
|
|
—
|
|
|
|
4,000
|
|
Investor relations
|
|
|
2,500
|
|
|
|
—
|
|
Total prepaid expenses
|
|
$
|
48,500
|
|
|
$
|
10,000
|
|
Note 6–
Concentration of Credit Risk
Cash
Financial instruments that potentially subject the Company to concentrations
of credit risk consist principally of cash. The Company maintains
cash balances at
one financial institution, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). The FDIC
insured institution insures up to $250,000 on account balances.
Note
7 –
Note Payable
Note
Payable Land
In
February, 2017, the Company entered into a land purchase contract to acquire approximately 80 acres including water and
mineral rights. The total cost of the land was $129,555. The Company paid $41,554 at closing and issued a note payable for
$88,000. As of December 31, 2017, the Company is on the deed of trust of the property with a remaining note balance of
$51,500 due the seller.
Note
8 –
Convertible Debt
2014
Convertible Note
In
January 2014, the Company entered into a Secured Promissory Note for $1,660,000 (the “2014 Company Note”) to Tonaquint,
Inc. (“Tonaquint”) which includes a purchase price of $1,500,000 and transaction costs of $160,000. On January 31,
2014, the Company received $300
,000 of the purchase price. Tonaquint also issued to the Company
6 secured promissory notes, each in the amount of $200,000 (the 2014 “Investor Notes”). All or any portion of the
outstanding balance of the 2014 Investor Notes may be prepaid, without penalty, along with accrued but unpaid interest at any
time prior to maturity. The Company has no obligation to pay Tonaquint any amounts on the unfunded portion of the 2014 Company
Note. The 2014 Company Note bears interest at 8% per annum (increases to 22% per annum upon an event of default) and is convertible
into shares of the Company’s common stock at Tonaquint’s option at a price of $0.55 per share, exercisable in seven
tranches, consisting of a first tranche of $340,000 of principal and any interest, fees costs or charges, and six additional tranches
of $220,000 each, plus any interest, costs, fees or charges.
Beginning on the
date that is six (6) months after the later of (i) the Issuance Date, and (ii) the date the Initial Cash Purchase Price is paid
to the Company (the “Initial Installment Date”), and on each applicable Installment Date thereafter, the Company is
to pay the Holder, the applicable Installment Amount due on such date. Ten Installment Amounts of $166,000 plus the sum of any
accrued and unpaid interest, fees, costs or charges may be made (a) in cash (a “Company Redemption”), (b) by converting
such Installment Amount into shares of Common Stock (a “Company Conversion”), or (c) by any combination of a Company
Conversion and a Company Redemption so long as the entire amount of such Installment Amount due shall be converted and/or redeemed
by the Company on the applicable Installment Date. The 2014 Company Note matured fifteen months after the Issuance Date.
As of December
31, 2015, $311,815 of principal and accrued interest of $1,041 is outstanding on the 2014 Company Note.
On January 19,
2016, the Company accepted and agreed to a Debt Purchase Agreement (the “DPA”), whereby LG Capital Funding, LLC (“LG”)
acquired $157,500 of the Tonaquint 2014 Convertible Note in exchange for $75,000. The Company issued an 8% Replacement Note to
LG for $157,500 (the “First Replacement Note”). The First Replacement Note was due January 19, 2017 and was convertible
into shares of the Company’s common stock at any time at the discretion of LG at a variable conversion price (“VCP”).
The VCP is calculated as the lowest trading price during the eighteen (18) trading days immediately prior to the conversion date
multiplied by fifty eight percent (58%), representing a forty two percent (42%) discount. On January 19, 2016, the Company recorded
a debt discount on the note of $157,500 and for the year ended December 31, 2016 recorded amortization expense of $151,813. The
principal and interest balance of the First Replacement Note as of December 31, 2016, was $157,500 and $12,145, respectively.
During the year ended December 31, 2017, the Company issued 12,268,244 shares of common stock upon the conversion of $157,500
of principal and $13,242 accrued and unpaid interest on the First Replacement Note. For the year ended December 31, 2017, the
Company recorded amortization expense of $5,687 on the remaining amount of the debt discount. The shares were issued at approximately
$0.014 per share.
As of December 31, 2017, principal and interest were paid in full with
stock, mentioned above, and the conversions occurred within the terms of the note agreement, as such, no gain or loss was recognized
upon the conversion.
On January 19,
2016, the Company accepted and agreed to a DPA, whereby Cerberus Finance Group, LTD (“Cerberus”) acquired $154,315
of principal and $2,434 of accrued and unpaid interest of the Tonaquint 2014 Convertible Note in exchange for $75,000. The Company
issued an 8% Replacement Note to Cerberus for $156,749 (the “Second Replacement Note”). The Second Replacement Note
was due January 19, 2017 and was convertible into shares of the Company’s common stock at any time at the discretion of
LG at a VCP. The VCP is calculated as the lowest trading price during the eighteen (18) trading days immediately prior to the
conversion date multiplied by fifty eight percent (58%), representing a forty two percent (42%) discount. On January 19, 2016,
the Company recorded a debt discount on the note of $156,749 and for the year ended December 31, 2016 recorded amortization expense
of $151,432. During the year ended December 31, 2016, the Company issued 13,129,683 shares of common stock upon the conversion
of $9,500 of principal and $400 accrued and unpaid interest on the Second Replacement Note. The shares were issued at approximately
$0.000754 per share. The principal and interest balance of the Second Replacement Note as of December 31, 2016, was $147,249 and
$11,617, respectively. During the year ended December 31, 2017, the Company issued 11,059,977 shares of common stock upon the
conversion of $147,249 of principal and $11,749 accrued and unpaid interest on the Second Replacement Note. For the year ended
December 31, 2017, the Company recorded amortization expense of $5,317 on the remaining amount of the debt discount. The shares
were issued at approximately $0.0144 per share.
As of December 31, 2017, principal and interest
were paid in full with stock, mentioned above, and the conversions occurred within the terms of the note agreement, as such, no
gain or loss was recognized upon the conversion.
2016 Convertible
Notes
On January 19,
2016, the Company completed the closing of a private placement financing transaction with LG, pursuant to a Securities Purchase
Agreement (the “LG Purchase Agreement”). Pursuant to the LG Purchase Agreement, LG purchased an 8% Convertible Debenture
(the “LG Debenture”) in the aggregate principal amount of $76,080, and delivered on January 31, 2016, gross proceeds
of $62,500 excluding transaction costs, fees, and expenses. The Company recorded a debt discount of $76,080 and during the year
ended December 31, 2016, recorded amortization expense of $72,911. The principal and interest balance of the note as of December
31, 2016 was $76,080 and $5,833, respectively. During the year ended December 31, 2017, the Company issued 28,295,680 shares of
common stock upon the conversion of $76,080 of principal and $4,752 accrued and unpaid interest on the note. The shares were issued
at approximately $0.0097 per share. During the year ended December 31, 2017, the Company recorded amortization expense of $3,170
for the remaining portion of the debt discount.
As of December 31, 2017, principal and interest
were paid in full with stock, mentioned above, and the conversions occurred within the terms of the note agreement, as such, no
gain or loss was recognized upon the conversion.
On January 19,
2016, the Company also issued a back end note to LG, under the same terms and conditions, in the amount of $65,625. The back-end
note was funded July 14, 2016, upon the receipt of $62,500, excluding transaction costs, fees and expenses. The Company recorded
a debt discount of $65,625 and during the year ended December 31, 2016, recorded amortization expense of $47,396. The principal
and interest balance of the note as of December 31, 2016 was $65,625 and $2,465, respectively. During the year ended December
31, 2017, the Company issued 5,432,726 shares of common stock upon the conversion of $65,625 of principal and $3,698 accrued and
unpaid interest on the note. The shares were issued at approximately $0.01276 per share. During the year ended December 31, 2017,
the Company recorded amortization expense of $34,818 for the remaining portion of the debt discount.
As
of December 31, 2017, principal and interest were paid in full with stock, mentioned above, and the conversions occurred within
the terms of the note agreement, as such, no gain or loss was recognized upon the conversion.
On January 19,
2016, the Company completed the closing of a private placement financing transaction with Cerberus, pursuant to a Securities Purchase
Agreement (the “Cerberus Purchase Agreement”). Pursuant to the Cerberus Purchase Agreement, Cerberus purchased an
8% Convertible Debenture (the “Cerberus Debenture”) in the aggregate principal amount of $34,775, and delivered on
January 25, 2016, gross proceeds of $25,000 excluding transaction costs, fees, and expenses. The Company recorded a debt discount
of $34,475 and during the year ended December 31, 2016, recorded amortization expense of $32,843. The principal and interest balance
of the note as of December 31, 2016 was $34,775 and $2,496, respectively. During the year ended December 31, 2017, the Company
issued 2,953,523 shares of common stock upon the conversion of $34,775 of principal and $3,255 accrued and unpaid interest on
the note. The shares were issued at approximately $0.01287 per share. During the year ended December 31, 2017, the Company recorded
amortization expense of $1,982 for the remaining portion of the debt discount.
As of December
31, 2017, principal and interest were paid in full with stock, mentioned above, and the conversions occurred within the terms
of the note agreement, as such, no gain or loss was recognized upon the conversion.
On January 19,
2016, the Company also issued a back-end note to Cerberus, under the same terms and conditions, in the amount of $22,000. The
back-end note was funded August 1 upon receipt of $20,000, excluding transaction costs, fees and expenses. The Company recorded
a debt discount of $22,000 and during the year ended December 31, 2016, recorded amortization expense of $17,294. The principal
and interest balance of the note as of December 31, 2016 was $22,000 and $743, respectively. During the year ended December 31,
2017, the Company issued 4,264,903 shares of common stock upon the conversion of $22,000 of principal and $1,500 accrued and unpaid
interest on the note. The shares were issued at approximately $0.00551 per share. During the year ended December 31, 2017, the
Company recorded amortization expense of $4,706 for the remaining portion of the debt discount.
As
of December 31, 2017, principal and interest were paid in full with stock, mentioned above, and the conversions occurred within
the terms of the note agreement, as such, no gain or loss was recognized upon the conversion.
On March 23, 2016,
the Company completed the closing of a private placement financing transaction with Cerberus, pursuant to a Securities Purchase
Agreement (the “Cerberus Purchase Agreement”). Pursuant to the Cerberus Purchase Agreement, Cerberus purchased an
8% Convertible Debenture (the “Cerberus Debenture”) in the aggregate principal amount of $22,000, and delivered on
March 31, 2016, gross proceeds of $20,000 excluding transaction costs, fees, and expenses. The Company recorded a debt discount
of $22,000 and during the year ended December 31, 2016, recorded amortization expense of $16,989. The principal and interest balance
of the note as of December 31, 2016 was $22,000 and $1,271, respectively. During the year ended December 31, 2017, the Company
issued 3,023,338 shares of common stock upon the conversion of $22,000 of principal and $2,199 accrued and unpaid interest on
the note. The shares were issued at approximately $0.008 per share. During the year ended December 31, 2017, the Company recorded
amortization expense of $5,011 for the remaining portion of the debt discount.
As of December
31, 2017, principal and interest were paid in full with stock, mentioned above, and the conversions occurred within the terms
of the note agreement, as such, no gain or loss was recognized upon the conversion.
On April 15, 2016,
the Company completed the closing of a private placement financing transaction with LG, pursuant to a Securities Purchase Agreement
(the “LG Purchase Agreement”). Pursuant to the LG Purchase Agreement, LG purchased an 8% Convertible Debenture (the
“LG Debenture”) in the aggregate principal amount of $65,625, and delivered on April 15, 2016, gross proceeds of $62,500
excluding transaction costs, fees, and expenses. The Company recorded a debt discount of $65,625 and during the year ended December
31, 2016, recorded amortization expense of $47,396. The principal and interest balance of the note as of December 31, 2016 was
$65,625 and $3,792, respectively. During the year ended December 31, 2017, the Company issued 12,718,484 shares of common stock
upon the conversion of $65,625 of principal and $6,535 accrued and unpaid interest on the note. The shares were issued at approximately
$0.0057 per share. During the year ended December 31, 2017, the Company recorded amortization expense of $18,229 for the remaining
portion of the debt discount.
As of December 31, 2017, principal and interest were paid
in full with stock, mentioned above, and the conversions occurred within the terms of the note agreement, as such, no gain or
loss was recognized upon the conversion.
On October 14,
2016, the Company completed the closing of a private placement financing transaction with LG, pursuant to a Securities Purchase
Agreement (the “LG Purchase Agreement”). Pursuant to the LG Purchase Agreement, LG purchased an 8% Convertible Debenture
(the “LG Debenture”) in the aggregate principal amount of $32,813, and delivered on October 14, 2016, gross proceeds
of $30,813 excluding transaction costs, fees, and expenses. The Company recorded a debt discount of $30,813 and during the year
ended December 31, 2016, recorded amortization expense of $6,676. The principal and interest balance of the note as of December
31, 2016 was $32,813 and $569, respectively. During the year ended December 31, 2017, the Company issued 6,499,359 shares of common
stock upon the conversion of $32,813 of principal and $2,999 accrued and unpaid interest on the note. The shares were issued at
approximately $0.00551 per share. During the year ended December 31, 2017, the Company recorded amortization expense of $24,137
for the remaining portion of the debt discount.
As of December 31, 2017, principal and interest
were paid in full with stock, mentioned above, and the conversions occurred within the terms of the note agreement, as such, no
gain or loss was recognized upon the conversion.
On October 31,
2016, the Company entered into a Convertible Promissory Note ("St. George 2016 Notes") for $555,000 to St. George Investments,
LLC. (“St. George”) which includes a purchase price of $500,000 and transaction costs of $5,000 and OID interest of
$50,000. On October 31, 2016, the Company received $100,000 and recorded $115,000 as convertible note payable, including $5,000
of transaction costs and $10,000 OID interest. St. George also issued to the Company eight secured promissory notes, each in the
amount of $50,000. All or any portion of the outstanding balance of the St. George 2016 Notes may be prepaid, without penalty,
along with accrued but unpaid interest at any time prior to maturity. The Company has no obligation to pay St. George any amounts
on the unfunded portion of the St. George 2016 Notes. The St. George 2016 Note bears interest at 10% per annum (increases to 22%
per annum upon an event of default) and is convertible into shares of the Company’s common stock at St. George’s option
at a price of $0.05 per share. On December 14, 2016, St. George funded one of the secured promissory notes issued to the Company.
During the year ended December 31, 2016, the Company recorded debt discounts of $150,000 and during the year ended December 31,
2016, recorded amortization expense of $25,416. The principal and interest balance of the note as of December 31, 2016 was $170,000
and $1,933, respectively. During the year ended December 31, 2017, St. George funded the remaining secured promissory notes issued
to the Company. During the year ended December 31, 2017, the Company recorded debt discounts of $350,000 and during the year ended
December 31, 2017, recorded amortization expense of $474,584. During the year ended December 31, 2017, the Company issued 46,631,979
shares of common stock upon the conversion of $241,756 of principal and $21,249 accrued and unpaid interest on the note. The shares
were issued at approximately $0.00564 per share. The principal and interest balance of the note as of December 31, 2017, was $313,244
and $1,946, respectively.
Beginning on the
date that is six (6) months after the later of (i) the Issuance Date, and (ii) the date the Initial Cash Purchase Price is paid
to the Company (the “Initial Installment Date”), and on each applicable Installment Date thereafter, the Company is
to pay the Holder, the applicable Installment Amount due on such date. Five Installment Amounts of $111,000 plus the sum of any
accrued and unpaid interest, fees, costs or charges may be made (a) in cash (a “Company Redemption”), (b) by converting
such Installment Amount into shares of Common Stock (a “Company Conversion”), or (c) by any combination of a Company
Conversion and a Company Redemption so long as the entire amount of such Installment Amount due shall be converted and/or redeemed
by the Company on the applicable Installment Date. The St. George 2016 Note matures fifteen months after the Issuance Date.
On December 15,
2016, the Company completed the closing of a private placement financing transaction with LG, pursuant to a Securities Purchase
Agreement (the “LG Purchase Agreement”). Pursuant to the LG Purchase Agreement, LG purchased an 8% Convertible Debenture
(the “LG Debenture”) in the aggregate principal amount of $32,813, and delivered on December 15, 2016, gross proceeds
of $30,813 excluding transaction costs, fees, and expenses. During the year ended December 31, 2016, the Company recorded a debt
discount of $32,813 and during the year ended December 31, 2016, recorded amortization expense of $1,369. The principal and interest
balance of the note as of December 31, 2016 was $32,813 and $117, respectively. During the year ended December 31, 2017, the Company
issued 5,980,387 shares of common stock upon the conversion of $32,813 of principal and $2,567 accrued and unpaid interest on
the note. The shares were issued at approximately $0.005916 per share. During the year ended December 31, 2017, the Company recorded
amortization expense of $29,443 for the remaining portion of the debt discount.
As of December
31, 2017, principal and interest were paid in full with stock, mentioned above, and the conversions occurred within the terms
of the note agreement, as such, no gain or loss was recognized upon the conversion.
Also, on December
15, 2016, the Company issued to LG, a back-end note under the same terms and conditions, in the amount of $32,813. On September
28, 2017, the back-end note was funded upon receipt of $30,813, excluding transaction costs, fees, and expenses. During the year
ended December 31, 2017, the Company recorded a debt discount of $30,813 and during the year ended December 31, 2017, recorded
amortization expense of $30,813. During the year ended December 31, 2017, the Company issued 5,793,378 shares of common stock
upon the conversion of $32,813 of principal and $453 accrued and unpaid interest on the note. The shares were issued at approximately
$0.005742 per share.
As of December 31, 2017, principal and interest were paid in full with
stock, mentioned above, and the conversions occurred within the terms of the note agreement, as such, no gain or loss was recognized
upon the conversion.
Principal and interest
on the above LG and Cerberus convertible debentures is due and payable one year from their respective funding date, and the LG
and Cerberus Debentures are convertible into shares of the Company’s common stock at any time at the discretion of LG and
Cerberus, respectively, at a VCP. The VCP is calculated as the lowest trading price during the eighteen (18) trading days immediately
prior to the conversion date multiplied by fifty eight percent (58%), representing a forty two percent (42%) discount.
The Company determined
that the conversion feature of the 2016 Convertible Notes represent an embedded derivative since the Notes are convertible into
a variable number of shares upon conversion. Accordingly, the 2016 Convertible Notes were not considered to be conventional debt
under ASC 815-40 (formerly EITF 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in,
a Company’s Own Stock) and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative
liability. Accordingly, the fair value of these derivative instruments being recorded as a liability on the consolidated balance
sheet with the corresponding amount recorded as a discount to each Note. Such discount is being amortized from the date of issuance
to the maturity dates of the Notes. The change in the fair value of the liability for derivative contracts are recorded in other
income or expenses in the consolidated statements of operations at the end of each quarter, with the offset to the derivative
liability on the balance sheet. The embedded feature included in the 2016 Convertible Notes resulted in an initial debt discount
of $865,593, an initial derivative liability expense of $2,317,830 and an initial derivative liability of $3,183,423. Amortization
of debt discount on the notes issued in 2016 was $257,033 and $608,560 for the years ended December 31, 2017 and 2016, respectively.
2017 Convertible
Notes
On January 24,
2017, the Company completed the closing of a private placement financing transaction with LG, pursuant to a Securities Purchase
Agreement (the “LG Purchase Agreement”). Pursuant to the LG Purchase Agreement, LG purchased an 8% Convertible Debenture
(the “LG Debenture”) in the aggregate principal amount of $94,500, and delivered on January 25, 2017, gross proceeds
of $90,000 excluding transaction costs, fees, and expenses. During the year ended December 31, 2017, the Company recorded a debt
discount of $90,000 and during the year ended December 31, 2017, recorded amortization expense of $90,000. During the year ended
December 31, 2017, the Company issued 17,440,037 shares of common stock upon the conversion of $94,500 of principal and $6,051
accrued and unpaid interest on the note. The shares were issued at approximately $0.00577 per share.
As
of December 31, 2017, principal and interest were paid in full with stock, mentioned above, and the conversions occurred within
the terms of the note agreement, as such, no gain or loss was recognized upon the conversion.
Also, on January 24, 2017,
the Company issued to LG, a back-end note under the same terms and conditions, in the amount of $94,500. On June 26, 2017, the
back-end note was funded upon receipt of $90,000, excluding transaction costs, fees, and expenses. During the year ended December
31, 2017, the Company recorded a debt discount of $86,340 and during the year ended December 31, 2017, recorded amortization expense
of $86,340. During the year ended December 31, 2017, the Company issued 13,697,874 shares of common stock upon the conversion
of $94,500 of principal and $2,178 accrued and unpaid interest on the back-end note. The shares were issued at approximately $0.00706
per share.
As of December 31, 2017, principal and interest were paid in full with stock,
mentioned above, and the conversions occurred within the terms of the note agreement, as such, no gain or loss was recognized
upon the conversion.
On January 24,
2017, the Company completed the closing of a private placement financing transaction with Cerberus, pursuant to a Securities Purchase
Agreement (the “Cerberus Purchase Agreement”). Pursuant to the Cerberus Purchase Agreement, Cerberus purchased an
8% Convertible Debenture (the “Cerberus Debenture”) in the aggregate principal amount of $63,000, and delivered on
January 25, 2017, gross proceeds of $60,000 excluding transaction costs, fees, and expenses. During the year ended December 31,
2017, the Company recorded a debt discount of $60,000 and during the year ended December 31, 2017, recorded amortization expense
of $60,000. During the year ended December 31, 2017, the Company issued 11,586,452 shares of common stock upon the conversion
of $63,000 of principal and $3,357 accrued and unpaid interest on the note. The shares were issued at approximately $0.00573 per
share.
As of December 31, 2017, principal and interest were paid in full with stock, mentioned
above, and the conversions occurred within the terms of the note agreement, as such, no gain or loss was recognized upon the conversion.
Also, on January 24, 2017, the Company issued to Cerberus, a back-end note under the same terms and conditions, in the
amount of $63,000. On June 30, 2017, the back-end note was funded upon receipt of $60,000, excluding transaction costs, fees,
and expenses. During the year ended December 31, 2017, the Company recorded a debt discount of $56,340 and during the year ended
December 31, 2017, recorded amortization expense of $53,367. The principal and interest balance of the back-end note as of December
31, 2017 was $63,000 and $2,632, respectively.
On February 1,
2017, the Company completed the closing of a private placement financing transaction with Power Up Lending Group, LTD (“Power
Up”), pursuant to a Securities Purchase Agreement (the “Power Up Purchase Agreement”). Pursuant to the Power
Up Purchase Agreement, Power Up purchased an 12% Convertible Debenture (the “Power Up Debenture”) in the aggregate
principal amount of $140,000, and delivered on February 3, 2017 (the “Funding Date”), gross proceeds of $136,500 excluding
transaction costs, fees, and expenses. Principal and interest on the Power Up Debentures is due and payable on November 5, 2017,
and the Power Up Debenture is convertible into shares of the Company’s common stock beginning six months from the Funding
Date, at a VCP. The VCP is calculated as the average of the three (3) lowest closing bid price during the ten (10) trading days
immediately prior to the conversion date multiplied by fifty eight percent (58%), representing a forty two percent (42%) discount.
During the year ended December 31, 2017, the Company recorded a debt discount of $136,500 and during the year ended December 31,
2017, recorded amortization expense of $136,500. The Company may prepay the Power Up Debenture, subject to prior notice to the
holder within an initial 30-day period after issuance, by paying an amount equal to 120% multiplied by the amount that the Company
is prepaying. For each additional 30-day period the amount being prepaid is multiplied by an additional 5%, up to a maximum of
140% on the 180
th
day from issuance. Beginning on the 180
th
day after the issuance of the Debentures,
the Company is not permitted to prepay the Debenture, so long as the Debenture is still outstanding, unless the Company and the
holder agree otherwise in writing. On June 23, 2017, the Company accepted and agreed to Assignment Agreements (‘AA”),
whereby, Power Up assigned $70,000 of their note to LG, and $70,000 of their note to Cerberus. As part of the AA, the Company
agreed to pay Power Up $65,000. The Company issued an 8% Replacement Note to LG for $73,198 (the “First Power Up Replacement
Note”), and an 8% Replacement Note to Cerberus for $73,198 (the “Second Power Up Replacement Note”) The First
and Second Power Up Replacement Notes are due June 23, 2018 and are convertible into shares of the Company’s common stock
at any time at the discretion of LG and Cerberus, respectively, at a VCP. The VCP is calculated as the lowest trading price during
the eighteen (18) trading days immediately prior to the conversion date multiplied by fifty eight percent (58%), representing
a forty two percent (42%) discount. During the year ended December 31, 2017, the Company recorded a debt discount of $73,198 for
the First Power up Replacement Note and during the year ended December 31, 2017, recorded amortization expense of $73,198. During
the year ended December 31, 2017, the Company issued 12,721,391 shares of common stock upon the conversion of $73,198 of principal
and $967 accrued and unpaid interest on the First Power Up Replacement Note. The shares were issued at approximately $0.00583
per share. The principal balance of the First Power Up Replacement Note as of December 31, 2017 was $-0-. During the year ended
December 31, 2017, the Company recorded a debt discount of $73,198 for the Second Power up Replacement Note and during the year
ended December 31, 2017, recorded amortization expense of $38,836. The principal and interest balance of the Second Power Up Replacement
Note as of December 31, 2017 was $73,199 and $3,107 respectively.
On February 24,
2017, the Company completed the closing of a private placement financing transaction with LG. Pursuant to the LG Purchase Agreement,
LG purchased an 8% Convertible Debenture in the aggregate principal amount of $26,000, and delivered on February 24, 2017, gross
proceeds of $24,000 excluding transaction costs, fees, and expenses. During the year ended December 31, 2017, the Company recorded
a debt discount of $24,000 and during the year ended December 31, 2017, recorded amortization expense of $24,000. On December
29,2017, the Company paid LG $35,421 to redeem the note, including $7,723 of excess over principal and interest due.
As
of December 31, 2017, principal and interest were paid in full with stock, mentioned above, and the conversions occurred within
the terms of the note agreement, as such, no gain or loss was recognized upon the conversion.
On February 24,
2017, the Company completed the closing of a private placement financing transaction with Cerberus, pursuant to a Securities Purchase
Agreement (the “Cerberus Purchase Agreement”). Pursuant to the Cerberus Purchase Agreement, Cerberus purchased an
8% Convertible Debenture (the “Cerberus Debenture”) in the aggregate principal amount of $17,500, and delivered on
February 27, 2017, gross proceeds of $16,000 excluding transaction costs, fees, and expenses. During the year ended December 31,
2017, the Company recorded a debt discount of $16,000 and during the year ended December 31, 2017, recorded amortization expense
of $13,644. The principal and interest balance of the note as of December 31, 2017 was $17,500 and $1,206, respectively. Also,
on February 24, 2017, the Company issued to Cerberus, a back-end note under the same terms and conditions, in the amount of $17,500.
On December 7, 2017, the back-end note was funded upon receipt of $16,000, excluding transaction costs, fees, and expenses. During
the year ended December 31, 2017, the Company recorded a debt discount of $16,000 and during the year ended December 31, 2017,
recorded amortization expense of $4,861. The principal and interest balance of the back-end note as of December 31, 2017 was $17,500
and $80, respectively.
On March 24, 2017,
the Company completed the closing of a private placement financing transaction with LG. Pursuant to the LG Purchase Agreement,
LG purchased an 8% Convertible Debenture in the aggregate principal amount of $52,000, and delivered on March 28, 2017, gross
proceeds of $49,600 excluding transaction costs, fees, and expenses. During the year ended December 31, 2017, the Company recorded
a debt discount of $49,400 and during the year ended December 31, 2017, recorded amortization expense of $49,400. On December
29,2017, the Company paid LG $70,376 to redeem the note, including $15,344 of excess over principal and interest due. The principal
balance of the note as of December 31, 2017 was $-0-. Also, on March 24, 2017, the Company issued to LG, a back-end note under
the same terms and conditions, in the amount of $52,000. On September 28, 2017, the back-end note was funded upon receipt of $49,600,
excluding transaction costs, fees, and expenses. During the year ended December 31, 2017, the Company recorded a debt discount
of $49,400 and during the year ended December 31, 2017, recorded amortization expense of $49,400. During the year ended December
31, 2017, the Company issued 8,939,991 shares of common stock upon the conversion of $52,000 of principal and $889 accrued and
unpaid interest on the note. The shares were issued at approximately $0.00592 per share.
As
of December 31, 2017, principal and interest were paid in full with stock, mentioned above, and the conversions occurred within
the terms of the note agreement, as such, no gain or loss was recognized upon the conversion.
On April 24, 2017,
the Company completed the closing of a private placement financing transaction with Cerberus, pursuant to a Securities Purchase
Agreement (the “Cerberus Purchase Agreement”). Pursuant to the Cerberus Purchase Agreement, Cerberus purchased an
8% Convertible Debenture (the “Cerberus Debenture”) in the aggregate principal amount of $42,000, and delivered on
May 3, 2017, gross proceeds of $40,000 excluding transaction costs, fees, and expenses. During the year ended December 31, 2017,
the Company recorded a debt discount of $40,000 and during the year ended December 31, 2017, recorded amortization expense of
$40,000. During the year ended December 31, 2017, the Company issued 6,570,945 shares of common stock upon the conversion of $42,000
of principal and $2,209 accrued and unpaid interest on the note. The shares were issued at approximately $0.00673 per share.
As
of December 31, 2017, principal and interest were paid in full with stock, mentioned above, and the conversions occurred within
the terms of the note agreement, as such, no gain or loss was recognized upon the conversion.
On May 24, 2017,
the Company completed the closing of a private placement financing transaction with LG. Pursuant to the LG Purchase Agreement,
LG purchased an 8% Convertible Debenture in the aggregate principal amount of $52,000, and delivered on May 24, 2017, gross proceeds
of $49,600 excluding transaction costs, fees, and expenses. During the year ended December 31, 2017, the Company recorded a debt
discount of $49,400 and during the year ended December 31, 2017, recorded amortization expense of $49,400. On December 29,2017,
the Company paid LG $69,545 to redeem the note, including $15,163 of excess over principal and interest due. The principal balance
of the note as of December 31, 2017 was $-0-. Also, on May 24, 2017, the Company issued to LG, a back-end note under the same
terms and conditions, in the amount of $52,000. On December 4, 2017, the back-end note was funded upon receipt of $49,600, excluding
transaction costs, fees, and expenses. During the year ended December 31, 2017, the Company recorded a debt discount of $49,400
and during the year ended December 31, 2017, recorded amortization expense of $49,400. On December 29,2017, the Company paid LG
$66,718 to redeem the back-end note, including $14,547 of excess over principal and interest due. The principal balance of the
back-end note as of December 31, 2017 was $-0-.
On August 8, 2017,
the Company completed the closing of a private placement financing transaction with Power Up, pursuant to a Securities Purchase
Agreement (the “Power Up Purchase Agreement”). Pursuant to the Power Up Purchase Agreement, Power Up purchased an
12% Convertible Debenture (the “Power Up Debenture”) in the aggregate principal amount of $128,000, and delivered
on August 9, 2017 (the “Funding Date”), gross proceeds of $125,000 excluding transaction costs, fees, and expenses.
Principal and interest on the Power Up Debentures is due and payable on May 15, 2018, and the Power Up Debenture is convertible
into shares of the Company’s common stock beginning six months from the Funding Date, at a VCP. The VCP is calculated as
the average of the three (3) lowest closing bid price during the ten (10) trading days immediately prior to the conversion date
multiplied by fifty eight percent (58%), representing a forty two percent (42%) discount. During the year ended December 31, 2017,
the Company recorded a debt discount of $125,000 and during the year ended December 31, 2017, recorded amortization expense of
$125,000. The Company may prepay the Power Up Debenture, subject to prior notice to the holder within an initial 30-day period
after issuance, by paying an amount equal to 120% multiplied by the amount that the Company is prepaying. For each additional
30-day period the amount being prepaid is multiplied by an additional 5%, up to a maximum of 140% on the 180
th
day
from issuance. Beginning on the 180
th
day after the issuance of the Debentures, the Company is not permitted to
prepay the Debenture, so long as the Debenture is still outstanding, unless the Company and the holder agree otherwise in writing.
On December 21,2017, the Company paid Power Up $177,639 to redeem the note, including $44,087 of excess over principal and interest
due. The principal balance of the note as of December 31, 2017 was $-0-.
On December 20,
2017, the Company entered into a Convertible Promissory Note ("St. George 2017 Notes") for $1,105,000 to St. George
which includes a purchase price of $1,000,000 and transaction costs of $5,000 and OID interest of $100,000. On December 21, 2017,
the Company received $200,000 and recorded $225,000 as convertible note payable, including $5,000 of transaction costs and $20,000
OID interest. St. George also issued to the Company four secured promissory notes, each in the amount of $200,000. All or any
portion of the outstanding balance of the St. George 2017 Notes may be prepaid, without penalty, along with accrued but unpaid
interest at any time prior to maturity. The Company has no obligation to pay St. George any amounts on the unfunded portion of
the St. George 2017 Notes. The St. George 2017 Note bears interest at 10% per annum (increases to 22% per annum upon an event
of default) and is convertible into shares of the Company’s common stock at St. George’s option at a price of $0.05
per share. On December 27, 2017, St. George funded $250,000 of the secured promissory notes issued to the Company, and the Company
recorded $270,000 as convertible note payable, including $20,000 OID interest. During the year ended December 31, 2017, the Company
recorded debt discounts of $450,000 and during the year ended December 31, 2017, recorded amortization expense of $6,637. The
principal and interest balance of the St George 2017 Note as of December 31, 2017, was $495,000 and $926, respectively.
Principal and interest
on the 2017 LG and Cerberus Debentures above is due and payable one year from their respective funding date, and the LG and Cerberus
Debentures are convertible into shares of the Company’s common stock at any time at the discretion of LG and Cerberus, respectively,
at a VCP. The VCP is calculated as the lowest trading price during the eighteen (18) trading days immediately prior to the conversion
date multiplied by fifty eight percent (58%), representing a forty two percent (42%) discount.
The Company may
prepay the 2017 LG and/or the Cerberus Debentures, subject to prior notice to the holder within an initial 30-day period after
issuance, by paying an amount equal to 118% multiplied by the amount that the Company is prepaying. For each additional 30-day
period the amount being prepaid is multiplied by an additional 6%, up to a maximum of 148% on the 180
th
day from issuance.
Beginning on the 180
th
day after the issuance of the Debentures, the Company is not permitted to prepay the Debenture,
so long as the Debenture is still outstanding, unless the Company and the holder agree otherwise in writing.
The Company determined
that the conversion feature of the 2017 Convertible Notes represent an embedded derivative since the Notes are convertible into
a variable number of shares upon conversion. Accordingly, the 2017 Convertible Notes were not considered to be conventional debt
under ASC 815-40 (formerly EITF 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in,
a Company’s Own Stock) and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative
liability. Accordingly, the fair value of these derivative instruments being recorded as a liability on the consolidated balance
sheet with the corresponding amount recorded as a discount to each Note. Such discount is being amortized from the date of issuance
to the maturity dates of the Notes. The change in the fair value of the liability for derivative contracts are recorded in other
income or expenses in the consolidated statements of operations at the end of each quarter, with the offset to the derivative
liability on the balance sheet. The embedded feature included in the 2017 Convertible Notes resulted in an initial debt discount
of $1,824,991, an initial derivative liability expense of $1,808,511 and an initial derivative liability of $3,633,502. For the
ear ended December 31, 2017, the Company recorded amortization expense on the debt discounts of the 2017 Notes of $1,330,798,
and there remains $494,193 of unamortized debt discount as of December 31, 2017.
The total
amount paid to redeem convertible notes and accrued interest during the year ended December 31, 2017, was $419,699, including $96,864 of
excess over principal and interest due.
Convertible
Note Conversions
During the year
ended December 31, 2017, the Company issued the following shares of common stock upon the conversions of portions of the Convertible
Notes:
Date
|
|
Principal Conversion
|
|
Interest Conversion
|
|
Total Conversion
|
|
Conversion Price
|
|
Shares Issued
|
|
Issued to
|
|
1/10/17
|
|
|
$
|
73,000
|
|
|
$
|
5,664
|
|
|
$
|
78,664
|
|
|
$
|
0.01595
|
|
|
|
4,931,912
|
|
|
Cerberus
|
|
1/17/17
|
|
|
$
|
57,500
|
|
|
$
|
4,562
|
|
|
$
|
62,062
|
|
|
$
|
0.01537
|
|
|
|
4,037,878
|
|
|
LG
|
|
1/27/17
|
|
|
$
|
48,129
|
|
|
$
|
3,914
|
|
|
$
|
52,043
|
|
|
$
|
0.01276
|
|
|
|
4,078,598
|
|
|
Cerberus
|
|
2/8/17
|
|
|
$
|
60,000
|
|
|
$
|
5,050
|
|
|
$
|
65,050
|
|
|
$
|
0.012934
|
|
|
|
5,029,369
|
|
|
LG
|
|
2/27/17
|
|
|
$
|
26,120
|
|
|
$
|
2,171
|
|
|
$
|
28,291
|
|
|
$
|
0.013804
|
|
|
|
2,049,467
|
|
|
Cerberus
|
|
3/10/17
|
|
|
$
|
40,000
|
|
|
$
|
3,630
|
|
|
$
|
43,630
|
|
|
$
|
0.01363
|
|
|
|
3,200,997
|
|
|
LG
|
|
3/27/17
|
|
|
$
|
34,775
|
|
|
$
|
3,255
|
|
|
$
|
38,030
|
|
|
$
|
0.012876
|
|
|
|
2,953,523
|
|
|
Cerberus
|
|
3/28/17
|
|
|
$
|
65,625
|
|
|
$
|
3,697
|
|
|
$
|
69,322
|
|
|
$
|
0.01276
|
|
|
|
5,432,725
|
|
|
LG
|
|
4/25/17
|
|
|
$
|
76,081
|
|
|
$
|
4,752
|
|
|
$
|
80,833
|
|
|
$
|
0.009744
|
|
|
|
8,295,680
|
|
|
LG
|
|
5/10/17
|
|
|
$
|
22,000
|
|
|
$
|
2,199
|
|
|
$
|
24,199
|
|
|
$
|
0.008
|
|
|
|
3,023,338
|
|
|
Cerberus
|
|
5/10/17
|
|
|
$
|
20,640
|
|
|
$
|
9,360
|
|
|
$
|
30,000
|
|
|
$
|
0.0075
|
|
|
|
4,000,000
|
|
|
St Georges
|
|
5/25/17
|
|
|
$
|
29,052
|
|
|
$
|
947
|
|
|
$
|
30,000
|
|
|
$
|
0.00564
|
|
|
|
5,319,149
|
|
|
St Georges
|
|
6/6/17
|
|
|
$
|
32,813
|
|
|
$
|
2,999
|
|
|
$
|
35,811
|
|
|
$
|
.00551
|
|
|
|
6,499,359
|
|
|
LG
|
|
6/8/17
|
|
|
$
|
34,100
|
|
|
$
|
900
|
|
|
$
|
35,000
|
|
|
$
|
0.00564
|
|
|
|
6,205,674
|
|
|
St Georges
|
|
6/9/17
|
|
|
$
|
22,000
|
|
|
$
|
1,500
|
|
|
$
|
23,500
|
|
|
$
|
0.00551
|
|
|
|
4,264,903
|
|
|
Cerberus
|
|
6/29/17
|
|
|
$
|
48,849
|
|
|
$
|
1,151
|
|
|
$
|
50,000
|
|
|
$
|
.00564
|
|
|
|
8,865,248
|
|
|
St Georges
|
|
6/30/17
|
|
|
$
|
30,625
|
|
|
$
|
2,960
|
|
|
$
|
33,585
|
|
|
$
|
0.0058
|
|
|
|
5,790,541
|
|
|
LG
|
|
7/17/17
|
|
|
$
|
37,358
|
|
|
$
|
733
|
|
|
$
|
38,091
|
|
|
$
|
0.00564
|
|
|
|
6,753,817
|
|
|
St Georges
|
|
7/25/17
|
|
|
$
|
35,000
|
|
|
$
|
3,575
|
|
|
$
|
38,575
|
|
|
$
|
0.005568
|
|
|
|
6,927,943
|
|
|
LG
|
|
7/26/17
|
|
|
$
|
28,000
|
|
|
$
|
1,117
|
|
|
$
|
29,117
|
|
|
$
|
0.005568
|
|
|
|
5,229,334
|
|
|
Cerberus
|
|
8/15/17
|
|
|
$
|
35,199
|
|
|
$
|
409
|
|
|
$
|
35,608
|
|
|
$
|
0.0058
|
|
|
|
6,139,276
|
|
|
LG
|
|
8/29/17
|
|
|
$
|
38,000
|
|
|
$
|
558
|
|
|
$
|
38,558
|
|
|
$
|
0.005858
|
|
|
|
6,582,115
|
|
|
LG
|
|
9/19/17
|
|
|
$
|
34,500
|
|
|
$
|
665
|
|
|
$
|
35,165
|
|
|
$
|
0.008178
|
|
|
|
4,300,002
|
|
|
LG
|
|
10/9/17
|
|
|
$
|
30,000
|
|
|
$
|
710
|
|
|
$
|
30,710
|
|
|
$
|
0.007076
|
|
|
|
4,340,042
|
|
|
LG
|
|
10/23/17
|
|
|
$
|
30,000
|
|
|
$
|
802
|
|
|
$
|
30,802
|
|
|
$
|
0.006090
|
|
|
|
5,057,830
|
|
|
LG
|
|
11/6/17
|
|
|
$
|
28,376
|
|
|
$
|
6,624
|
|
|
$
|
35,000
|
|
|
$
|
0.005640
|
|
|
|
6,205,674
|
|
|
St Georges
|
|
11/6/17
|
|
|
$
|
19,500
|
|
|
$
|
1,218
|
|
|
$
|
20,718
|
|
|
$
|
0.005858
|
|
|
|
3,536,715
|
|
|
LG
|
|
11/13/17
|
|
|
$
|
35,000
|
|
|
$
|
2,240
|
|
|
$
|
37,240
|
|
|
$
|
0.005858
|
|
|
|
6,357,118
|
|
|
Cerberus
|
|
11/14/17
|
|
|
$
|
26,624
|
|
|
$
|
428
|
|
|
$
|
27,052
|
|
|
$
|
0.005640
|
|
|
|
4,796,452
|
|
|
St Georges
|
|
11/15/17
|
|
|
$
|
75.000
|
|
|
$
|
4,833
|
|
|
$
|
79,833
|
|
|
$
|
0.005742
|
|
|
|
13,903,322
|
|
|
LG
|
|
12/1/17
|
|
|
$
|
32,813
|
|
|
$
|
453
|
|
|
$
|
33,266
|
|
|
$
|
0.005742
|
|
|
|
5,793,378
|
|
|
LG
|
|
12/5/17
|
|
|
$
|
16,756
|
|
|
$
|
1,105
|
|
|
$
|
17,861
|
|
|
$
|
0.005640
|
|
|
|
3,166,816
|
|
|
St Georges
|
|
12/7/17
|
|
|
$
|
32,813
|
|
|
$
|
2,567
|
|
|
$
|
35,380
|
|
|
$
|
0.005916
|
|
|
|
5,980,387
|
|
|
LG
|
|
12/15/17
|
|
|
$
|
52,000
|
|
|
$
|
889
|
|
|
$
|
52,889
|
|
|
$
|
0.005916
|
|
|
|
8,939,991
|
|
|
LG
|
|
12/28/17
|
|
|
$
|
42,000
|
|
|
$
|
2,209
|
|
|
$
|
44,209
|
|
|
$
|
0.006728
|
|
|
|
6,570,945
|
|
|
Cerberus
|
|
|
|
|
$
|
1,350,247
|
|
|
$
|
89,846
|
|
|
$
|
1,440,093
|
|
|
|
|
|
|
|
194,559,520
|
|
|
|
During the year
ended December 31, 2016, the Company issued the following shares of common stock upon the conversion of portions of the 2015
Convertible Notes and accrued interest thereon:
Date
|
|
Principal
Conversion
|
|
Interest
Conversion
|
|
Total
Conversion
|
|
Conversion
Price
|
|
Shares
Issued
|
|
Issued
to
|
|
12/28/16
|
|
|
$
|
45,000
|
|
|
$
|
3,511
|
|
|
$
|
48,511
|
|
|
$
|
0.015080
|
|
|
|
3,216,925
|
|
|
LG
|
|
12/13/16
|
|
|
$
|
9,500
|
|
|
$
|
400
|
|
|
$
|
9,900
|
|
|
$
|
0.000754
|
|
|
|
13,129,683
|
|
|
Cerberus
|
|
9/26/16
|
|
|
$
|
8,613
|
|
|
$
|
629
|
|
|
$
|
9,242
|
|
|
$
|
0.001218
|
|
|
|
7,587,824
|
|
|
LG
|
|
7/29/16
|
|
|
$
|
7,500
|
|
|
$
|
801
|
|
|
$
|
8,301
|
|
|
$
|
0.000081
|
|
|
|
10,222,352
|
|
|
LG
|
|
7/20/16
|
|
|
$
|
9,500
|
|
|
$
|
995
|
|
|
$
|
10,495
|
|
|
$
|
0.000098
|
|
|
|
10,644,310
|
|
|
LG
|
|
7/12/16
|
|
|
$
|
9,000
|
|
|
$
|
927
|
|
|
$
|
9,927
|
|
|
$
|
0.000986
|
|
|
|
10,068,073
|
|
|
LG
|
|
7/1/16
|
|
|
$
|
8,000
|
|
|
$
|
805
|
|
|
$
|
8,805
|
|
|
$
|
0.001160
|
|
|
|
7,590,362
|
|
|
LG
|
|
6/22/16
|
|
|
$
|
5,000
|
|
|
$
|
973
|
|
|
$
|
5,973
|
|
|
$
|
0.001450
|
|
|
|
4,119,414
|
|
|
GW
|
|
6/20/16
|
|
|
$
|
10,500
|
|
|
$
|
1,003
|
|
|
$
|
11,503
|
|
|
$
|
0.001450
|
|
|
|
7,933,377
|
|
|
Cerberus
|
|
6/20/16
|
|
|
$
|
5,000
|
|
|
$
|
967
|
|
|
$
|
5,967
|
|
|
$
|
0.001450
|
|
|
|
4,114,879
|
|
|
GW
|
|
6/20/16
|
|
|
$
|
6,000
|
|
|
$
|
589
|
|
|
$
|
6,589
|
|
|
$
|
0.001450
|
|
|
|
4,544,241
|
|
|
LG
|
|
6/10/16
|
|
|
$
|
6,075
|
|
|
$
|
1,134
|
|
|
$
|
7,209
|
|
|
$
|
0.001798
|
|
|
|
4,009,701
|
|
|
GW
|
|
6/9/16
|
|
|
$
|
5,000
|
|
|
$
|
479
|
|
|
$
|
5,479
|
|
|
$
|
0.001798
|
|
|
|
3,047,219
|
|
|
LG
|
|
6/2/16
|
|
|
$
|
9,000
|
|
|
$
|
848
|
|
|
$
|
9,848
|
|
|
$
|
0.002378
|
|
|
|
4,141,387
|
|
|
Cerberus
|
|
5/23/16
|
|
|
$
|
5,000
|
|
|
$
|
460
|
|
|
$
|
5,460
|
|
|
$
|
0.002436
|
|
|
|
2,241,490
|
|
|
LG
|
|
3/17/16
|
|
|
$
|
9,000
|
|
|
$
|
696
|
|
|
$
|
9,696
|
|
|
$
|
0.002436
|
|
|
|
3,980,431
|
|
|
LG
|
|
3/17/16
|
|
|
$
|
3,000
|
|
|
$
|
138
|
|
|
$
|
3,138
|
|
|
$
|
0.000638
|
|
|
|
4,918,624
|
|
|
Service
|
|
3/8/16
|
|
|
$
|
7,425
|
|
|
$
|
928
|
|
|
$
|
8,353
|
|
|
$
|
0.00174
|
|
|
|
4,800,354
|
|
|
GW
|
|
3/7/16
|
|
|
$
|
6,500
|
|
|
$
|
489
|
|
|
$
|
6,989
|
|
|
$
|
0.00174
|
|
|
|
4,016,471
|
|
|
LG
|
|
|
|
|
$
|
174,613
|
|
|
$
|
16,772
|
|
|
$
|
191,385
|
|
|
|
|
|
|
|
114,327,117
|
|
|
|
A summary of the
convertible notes payable balance as of December 31, 2017, and 2016 is as follows:
|
|
2017
|
|
2016
|
Beginning Principal Balance
|
|
$
|
826,480
|
|
|
$
|
472,515
|
|
Convertible notes-newly issued
|
|
|
1,813,210
|
|
|
|
521,731
|
|
Conversion of convertible notes (principal)
|
|
|
(1,350,247
|
)
|
|
|
6,848
|
|
Principal payments
|
|
|
(310,000
|
)
|
|
|
(174,613
|
)
|
Unamortized discount
|
|
|
(494,193
|
)
|
|
|
(257,033
|
)
|
Ending Principal Balance,
net
|
|
$
|
485,250
|
|
|
$
|
569,448
|
|
Note 9 -
Derivative
liabilities
As of December
31, 2017, the Company revalued the embedded conversion feature of the 2016 and 2017 Convertible Notes, and warrants (see note
11). The fair value of the 2016 and 2017 Convertible Notes and warrants was calculated at December 31, 2017 based on the Monte
Carlo simulation method consistent with the terms of the related debt.
A summary of the
derivative liability balance as of December 31, 2017, is as follows:
|
|
Notes
|
|
|
Warrants
|
|
|
|
Total
|
|
Beginning Balance
|
|
$
|
1,410,647
|
|
|
$
|
203,023
|
|
|
$
|
1,613,670
|
|
Initial Derivative Liability
|
|
|
3,633,502
|
|
|
|
415,313
|
|
|
|
4,048,815
|
|
Fair Value Change
|
|
|
1,571,986
|
|
|
|
1,190,244
|
|
|
|
2,762,230
|
|
Reclassified to Additional paid- in capital
|
|
|
(2,184,277
|
)
|
|
|
—
|
|
|
|
(2,184,277
|
)
|
Reduction for debt assignment
|
|
|
(823,610
|
)
|
|
|
—
|
|
|
|
(823,610
|
)
|
Ending Balance
|
|
$
|
3,608,250
|
|
|
$
|
1,808,580
|
|
|
$
|
5,416,830
|
|
The embedded derivative
within Warrant #’s 2 thru 9 (see Note 11) resulted in an initial derivative liability expense and an initial derivative
liability of $415,313. The valuation of the embedded derivative within the effective warrants was recorded with an offsetting
expense on derivative liabilities.
The fair value
at the commitment date for the 2017 Convertible Notes and the re-measurement dates for the Company’s derivative liabilities
were based upon the following management assumptions as of December 31, 2017:
|
|
Commitment
date
|
|
Remeasurement
date
|
Expected dividends
|
|
|
-0-
|
|
|
|
-0-
|
|
Expected volatility
|
|
|
199%-361%
|
|
|
|
320%-331%
|
|
Expected term
|
|
|
12 months
|
|
|
|
3-12 months
|
|
Risk free interest
|
|
|
.65%-1.78%
|
|
|
|
1.51%-1.79%
|
|
The Company evaluated
all outstanding warrants to determine whether these instruments may be tainted. All warrants outstanding were considered tainted.
The Company valued the embedded derivatives within the warrants using the Black-Scholes valuation model. The fair
value at the funding date for Warrant #’s 2-9 and the re-measurement dates for Warrant #’s 1-9 were based upon the
following management assumptions:
|
|
Commitment
date
|
|
Remeasurement
date
|
Expected dividends
|
|
|
-0-
|
|
|
|
-0-
|
|
Expected volatility
|
|
|
203% - 384%
|
|
|
|
320%
|
|
Expected term
|
|
|
3.87 - 4.64 years
|
|
|
|
3.84 years
|
|
Risk free interest
|
|
|
1.72% - 2.05%
|
|
|
|
1.81%
|
|
The Company
determined that the conversion feature of the 2016 Convertible Notes represent an embedded derivative since the Notes are convertible
into a variable number of shares upon conversion. Accordingly, the 2016 Convertible Notes were not considered to be conventional
debt under ASC 815-40 (formerly EITF 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled
in, a Company’s Own Stock) and the embedded conversion feature was bifurcated from the debt host and accounted for as a
derivative liability. Accordingly, the fair value of these derivative instruments being recorded as a liability on the consolidated
balance sheet with the corresponding amount recorded as a discount to each Note. Such discount is being amortized from the date
of issuance to the maturity dates of the Notes. The change in the fair value of the liability for derivative contracts are recorded
in other income or expenses in the consolidated statements of operations at the end of each quarter, with the offset to the derivative
liability on the balance sheet. The embedded feature included in the 2016 Convertible Notes resulted in an initial debt discount
of $865,593, an initial derivative liability expense of $2,317,830 and an initial derivative liability of $3,183,423.
As of December
31, 2016, the Company revalued the embedded conversion feature of the 2015 and 2016 Convertible Notes. The fair value of the 2015
and 2016 Convertible Notes was calculated at December 31, 2016 based on the Black Scholes method consistent with the terms
of the related debt.
A summary of the
derivative liability balance as of December 31, 2016 is as follows:
Beginning Balance
|
|
$
|
167,014
|
|
Initial Derivative Liability
|
|
|
4,114,649
|
|
Fair Value Change
|
|
|
(1,791,988
|
)
|
Debt extinguishment
|
|
|
(84,057
|
)
|
Reduction for conversions
|
|
|
(791,851
|
)
|
Ending Balance
|
|
$
|
1,613,767
|
|
The fair value
at the commitment date for the 2016 Convertible Notes and the re-measurement dates for the Company’s derivative liabilities
were based upon the following management assumptions as of December 31, 2016:
|
|
Commitment
date
|
|
Remeasurement
date
|
Expected dividends
|
|
|
-0-
|
|
|
|
-0-
|
|
Expected volatility
|
|
|
243%-268%
|
|
|
|
246%
|
|
Expected term
|
|
|
12 months
|
|
|
|
1-12 months
|
|
Risk free interest
|
|
|
.44%-.68%
|
|
|
|
.48%-.85%
|
|
Note 10 –
Related Party Transactions
Effective
January 1, 2013, the Company agreed to an annual compensation of $150,000 for its CEO, Mr. Michael Friedman (resigned March
20, 2015, re-appointed November 4, 2015). Effective March 20, 2015, Mr. Justin Braune was named CEO and President. Mr. Braune
also was appointed to the Board of Directors. The Company agreed to an annual compensation of $100,000 for Mr. Braune in his
role of CEO and Director of the Company and to issue Mr. Braune 15,000,000 shares of restricted common stock. Mr. Braune
resigned from the board of directors and as CEO on November 4, 2015, and agreed to cancel the 15,000,000 shares in his
letter of resignation. The Company also initially issued Mr. Braune 12,500,000 shares of common stock on October 13, 2015. On
October 16, 2015, Mr. Braune advised the Company’s transfer agent at the time to cancel the shares. The
Company’s transfer agent has not canceled the shares, and accordingly, as of December 31, 2017, the shares are included
in the outstanding shares of the Company. Management has requested that the transfer agent cancel the shares.
For the years ended
December 31, 2017 and 2016, the Company recorded expenses of $150,000 to the CEO, included in Management Fees in the consolidated
statements of operations, included herein. As of December 31, 2017, and 2016, the Company owed the CEO $7,715 and $54,246, respectively,
and is included in due to related party on the Company’s consolidated balance sheet. On January 30, 2017, the Company issued
10,000,000 shares of common stock to the Company’s CEO. The shares were issued for services performed as the sole Officer
and director of the Company since November 2014. The shares were valued at $301,000 ($0.0301 per share, the market price of the
common stock on the grant date) and are included in Management Fees in the consolidated statements of operations, included herein.
On April 14, 2015,
the Company appointed Dr. Stephen Holt to the Advisory Board of the Board of Directors of the Company. The Company issued 5,000,000
shares of restricted common stock to Dr. Holt for his appointment. Additionally, the Company agreed the advisor shall receive
a non-qualified stock option to purchase 1,000,000 shares (“Option Shares”) of the Company’s common stock at
an exercise price equal to $0.05 per share. 400,000 Option Shares vested immediately and the remaining 600,000 Option Shares vested
over 12 months. Accordingly, the Company has recorded $2,371 for the year ended December 31, 2016, in stock compensation expense
and all of the options have vested.
On October
5, 2017, the Company agreed to lease from the Company’s CEO, a "420 Style" resort and estate
property approximately one hour outside of Quebec City, Canada. The fifteen-acre estate consists of nine (9) unique guest
suites, horse stables, and is within walking distance to a public golf course. A separate structure will serve as a small
grow facility run by patient employees and caretakers on the property which may be toured by guests of the facility. Pursuant
to the agreement, the Company will pay $8,000 per month in exchange for the Company being entitled to all rents and
income generated from the property. The Company will be responsible for all costs of the property, including, but not limited
to, renovations, repairs and maintenance, insurance and utilities. On August 8, 2017, the Company issued 5,000,000 shares
of common stock to the seller. The Company valued the shares at $0.0123 per share (the market price of the common stock) and
has included $61,500 in stock- based compensation expense for the year ended December 31, 2017. The Company purchased from
the previous owner furniture and fixtures for $96,000. As of December 31, 2017, the Company has not received any rents from
the property, as it is renovating the house.
A
mounts
Due from 800 Commerce, Inc.
800 Commerce, Inc.,
a commonly controlled entity until February 29, 2016, owed Agritek $282,947 as of February 29, 2016, as a result of advances received
from or payments made by Agritek on behalf of 800 Commerce. These advances were non-interest bearing and were due on demand. Effective
February 29, 2016, the Company received 1,102,462 shares of common stock of Petrogress, Inc. (formerly known as 800 Commerce,
Inc.) as settlement of the $282,947 owed to the Company.
Note 11 –
Common and Preferred Stock
C
ommon
Stock
2017 Issuances
During the year
ended December 31, 2017, the Company issued the following shares of common stock upon the conversions of portions of the convertible
notes:
Date
|
|
Principal Conversion
|
|
Interest Conversion
|
|
Total Conversion
|
|
Conversion Price
|
|
Shares Issued
|
|
Issued to
|
|
1/10/17
|
|
|
$
|
73,000
|
|
|
$
|
5,664
|
|
|
$
|
78,664
|
|
|
$
|
0.01595
|
|
|
|
4,931,912
|
|
|
Cerberus
|
|
1/17/17
|
|
|
$
|
57,500
|
|
|
$
|
4,562
|
|
|
$
|
62,062
|
|
|
$
|
0.01537
|
|
|
|
4,037,878
|
|
|
LG
|
|
1/27/17
|
|
|
$
|
48,129
|
|
|
$
|
3,914
|
|
|
$
|
52,043
|
|
|
$
|
0.01276
|
|
|
|
4,078,598
|
|
|
Cerberus
|
|
2/8/17
|
|
|
$
|
60,000
|
|
|
$
|
5,050
|
|
|
$
|
65,050
|
|
|
$
|
0.012934
|
|
|
|
5,029,369
|
|
|
LG
|
|
2/27/17
|
|
|
$
|
26,120
|
|
|
$
|
2,171
|
|
|
$
|
28,291
|
|
|
$
|
0.013804
|
|
|
|
2,049,467
|
|
|
Cerberus
|
|
3/10/17
|
|
|
$
|
40,000
|
|
|
$
|
3,630
|
|
|
$
|
43,630
|
|
|
$
|
0.01363
|
|
|
|
3,200,997
|
|
|
LG
|
|
3/27/17
|
|
|
$
|
34,775
|
|
|
$
|
3,255
|
|
|
$
|
38,030
|
|
|
$
|
0.012876
|
|
|
|
2,953,523
|
|
|
Cerberus
|
|
3/28/17
|
|
|
$
|
65,625
|
|
|
$
|
3,697
|
|
|
$
|
69,322
|
|
|
$
|
0.01276
|
|
|
|
5,432,725
|
|
|
LG
|
|
4/25/17
|
|
|
$
|
76,081
|
|
|
$
|
4,752
|
|
|
$
|
80,833
|
|
|
$
|
0.009744
|
|
|
|
8,295,680
|
|
|
LG
|
|
5/10/17
|
|
|
$
|
22,000
|
|
|
$
|
2,199
|
|
|
$
|
24,199
|
|
|
$
|
0.008
|
|
|
|
3,023,338
|
|
|
Cerberus
|
|
5/10/17
|
|
|
$
|
20,640
|
|
|
$
|
9,360
|
|
|
$
|
30,000
|
|
|
$
|
0.0075
|
|
|
|
4,000,000
|
|
|
St Georges
|
|
5/25/17
|
|
|
$
|
29,052
|
|
|
$
|
947
|
|
|
$
|
30,000
|
|
|
$
|
0.00564
|
|
|
|
5,319,149
|
|
|
St Georges
|
|
6/6/17
|
|
|
$
|
32,813
|
|
|
$
|
2,999
|
|
|
$
|
35,811
|
|
|
$
|
.00551
|
|
|
|
6,499,359
|
|
|
LG
|
|
6/8/17
|
|
|
$
|
34,100
|
|
|
$
|
900
|
|
|
$
|
35,000
|
|
|
$
|
0.00564
|
|
|
|
6,205,674
|
|
|
St Georges
|
|
6/9/17
|
|
|
$
|
22,000
|
|
|
$
|
1,500
|
|
|
$
|
23,500
|
|
|
$
|
0.00551
|
|
|
|
4,264,903
|
|
|
Cerberus
|
|
6/29/17
|
|
|
$
|
48,849
|
|
|
$
|
1,151
|
|
|
$
|
50,000
|
|
|
$
|
.00564
|
|
|
|
8,865,248
|
|
|
St Georges
|
|
6/30/17
|
|
|
$
|
30,625
|
|
|
$
|
2,960
|
|
|
$
|
33,585
|
|
|
$
|
0.0058
|
|
|
|
5,790,541
|
|
|
LG
|
|
7/17/17
|
|
|
$
|
37,358
|
|
|
$
|
733
|
|
|
$
|
38,091
|
|
|
$
|
0.00564
|
|
|
|
6,753,817
|
|
|
St Georges
|
|
7/25/17
|
|
|
$
|
35,000
|
|
|
$
|
3,575
|
|
|
$
|
38,575
|
|
|
$
|
0.005568
|
|
|
|
6,927,943
|
|
|
LG
|
|
7/26/17
|
|
|
$
|
28,000
|
|
|
$
|
1,117
|
|
|
$
|
29,117
|
|
|
$
|
0.005568
|
|
|
|
5,229,334
|
|
|
Cerberus
|
|
8/15/17
|
|
|
$
|
35,199
|
|
|
$
|
409
|
|
|
$
|
35,608
|
|
|
$
|
0.0058
|
|
|
|
6,139,276
|
|
|
LG
|
|
8/29/17
|
|
|
$
|
38,000
|
|
|
$
|
558
|
|
|
$
|
38,558
|
|
|
$
|
0.005858
|
|
|
|
6,582,115
|
|
|
LG
|
|
9/19/17
|
|
|
$
|
34,500
|
|
|
$
|
665
|
|
|
$
|
35,165
|
|
|
$
|
0.008178
|
|
|
|
4,300,002
|
|
|
LG
|
|
10/9/17
|
|
|
$
|
30,000
|
|
|
$
|
710
|
|
|
$
|
30,710
|
|
|
$
|
0.007076
|
|
|
|
4,340,042
|
|
|
LG
|
|
10/23/17
|
|
|
$
|
30,000
|
|
|
$
|
802
|
|
|
$
|
30,802
|
|
|
$
|
0.006090
|
|
|
|
5,057,830
|
|
|
LG
|
|
11/6/17
|
|
|
$
|
28,376
|
|
|
$
|
6,624
|
|
|
$
|
35,000
|
|
|
$
|
0.005640
|
|
|
|
6,205,674
|
|
|
St Georges
|
|
11/6/17
|
|
|
$
|
19,500
|
|
|
$
|
1,218
|
|
|
$
|
20,718
|
|
|
$
|
0.005858
|
|
|
|
3,536,715
|
|
|
LG
|
|
11/13/17
|
|
|
$
|
35,000
|
|
|
$
|
2,240
|
|
|
$
|
37,240
|
|
|
$
|
0.005858
|
|
|
|
6,357,118
|
|
|
Cerberus
|
|
11/14/17
|
|
|
$
|
26,624
|
|
|
$
|
428
|
|
|
$
|
27,052
|
|
|
$
|
0.005640
|
|
|
|
4,796,452
|
|
|
St Georges
|
|
11/15/17
|
|
|
$
|
75,000
|
|
|
$
|
4,833
|
|
|
$
|
79,833
|
|
|
$
|
0.005742
|
|
|
|
13,903,322
|
|
|
LG
|
|
12/1/17
|
|
|
$
|
32,813
|
|
|
$
|
453
|
|
|
$
|
33,266
|
|
|
$
|
0.005742
|
|
|
|
5,793,378
|
|
|
LG
|
|
12/5/17
|
|
|
$
|
16,756
|
|
|
$
|
1,105
|
|
|
$
|
17,861
|
|
|
$
|
0.005640
|
|
|
|
3,166,816
|
|
|
St Georges
|
|
12/7/17
|
|
|
$
|
32,813
|
|
|
$
|
2,567
|
|
|
$
|
35,380
|
|
|
$
|
0.005916
|
|
|
|
5,980,387
|
|
|
LG
|
|
12/15/17
|
|
|
$
|
52,000
|
|
|
$
|
889
|
|
|
$
|
52,889
|
|
|
$
|
0.005916
|
|
|
|
8,939,991
|
|
|
LG
|
|
12/28/17
|
|
|
$
|
42,000
|
|
|
$
|
2,209
|
|
|
$
|
44,209
|
|
|
$
|
0.006728
|
|
|
|
6,570,945
|
|
|
Cerberus
|
|
|
|
|
$
|
1,350,247
|
|
|
$
|
89,846
|
|
|
$
|
1,440,093
|
|
|
|
|
|
|
|
194,559,520
|
|
|
|
In addition to
the above, during the year ended December 31, 2017, the Company:
On January 16,
2017, the Company entered into a Business Consultant Agreement (the “BCA”). Pursuant to the BCA, the Company issued
5,000,000 shares of common stock for services to be provided to the Company related to business development, product marketing,
helping identify mergers and acquisition candidates, and will consult with and advise the Company on matters pertaining to business
modeling and strategic alliances. The Company valued the shares at $0.0267 per share (the market price of the common stock) and
recorded stock compensation expense for the year ended December 31, 2017, of $133,500.
On January 27,
2017, the Company issued 1,000,000 shares of restricted common stock to Kopelowitz Ostrow P.A. (“
KO
”) pursuant
to a Debt Settlement and Release Agreement (the “Debt Settlement”) by and between the Company and KO. Among the terms
of the Debt Settlement was the forgiveness of $24,614 of debt the Company owed KO for legal services provided. The Company valued
the shares at $0.0257 per share (the market price of the common stock) and recorded a loss on the settlement of accounts payable
for the year ended December 31, 2017, of $1,086.
On January 30,
2017, the Company issued 1,000,000 shares of common stock to Venture Equity. The Company valued the shares at $0.03 per share
(the market price of the common stock) and cancelled of $13,169 of accrued and unpaid fees owed Venture Equity and recorded a
loss on the settlement of accounts payable for the year ended December 31, 2017, of $16,831.
Also, on January
30, 2017, the Company issued 10,000,000 shares of common stock to the Company’s CEO. The shares were issued for services
performed as the sole Officer and director of the Company since November 2014. The Company valued the shares at $0.0301 per share
(the market price of the common stock) and for the year ended December 31, 2017, recorded stock compensation expense, management,
of $301,000.
On June 19,
2017, the Company issued 1,319,149 shares of common stock valued at $16,094 to St. George pursuant to the
“true-up” terms and conditions of the St. George note.
On August 8, 2017,
the Company issued 2,000,000 shares of common stock for compensation for services of the Company’s chief operating officer.
The Company valued the shares at $0.0123 per share (the market price of the common stock) and for the year ended December 31,
2017, recorded stock compensation expense, management, of $24,600.
On August 8, 2017,
the Company issued 5,000,000 shares of common stock for the property known as the "420 Style" resort and estate, located
in Canada (see note 11). The Company valued the shares at $0.0123 per share (the market price of the common stock) and has included
$61,500 in stock- based compensation expense for the year ended December 31, 2017.
During the year
ended December 31, 2017, the Company issued 87,934,231 shares of common stock to St. George pursuant to Notices of Exercise of
Warrant received. The shares were issued based upon the cashless exercise provision of the warrant.
During the year ended December 31, 2017,
the Company recorded 15,000,000 shares of common stock to Mr. Braune (see Note 10) that have been included in
the Company’s transfer agent’s records despite Mr. Braune’s request to the transfer agent of record at the
time to cancel the shares. The Company had previously removed the shares from its records.
2016 Issuances
During the year
ended December 31, 2016, the Company issued the following shares of common stock upon the conversions of portions of the 2014
Company Note and portions of the 2015 Convertible Notes:
Date
|
|
Principal
Conversion
|
|
Interest
Conversion
|
|
Total
Conversion
|
|
Conversion
Price
|
|
Shares
Issued
|
|
Issued
to
|
|
12/28/16
|
|
|
$
|
45,000
|
|
|
$
|
3,511
|
|
|
$
|
48,511
|
|
|
$
|
0.015080
|
|
|
|
3,216,925
|
|
|
LG
|
|
12/13/16
|
|
|
$
|
9,500
|
|
|
$
|
400
|
|
|
$
|
9,900
|
|
|
$
|
0.000754
|
|
|
|
13,129,683
|
|
|
Cerberus
|
|
9/26/16
|
|
|
$
|
8,613
|
|
|
$
|
629
|
|
|
$
|
9,242
|
|
|
$
|
0.001218
|
|
|
|
7,587,824
|
|
|
LG
|
|
7/29/16
|
|
|
$
|
7,500
|
|
|
$
|
801
|
|
|
$
|
8,301
|
|
|
$
|
0.000081
|
|
|
|
10,222,352
|
|
|
LG
|
|
7/20/16
|
|
|
$
|
9,500
|
|
|
$
|
995
|
|
|
$
|
10,495
|
|
|
$
|
0.000098
|
|
|
|
10,644,310
|
|
|
LG
|
|
7/12/16
|
|
|
$
|
9,000
|
|
|
$
|
927
|
|
|
$
|
9,927
|
|
|
$
|
0.000986
|
|
|
|
10,068,073
|
|
|
LG
|
|
7/1/16
|
|
|
$
|
8,000
|
|
|
$
|
805
|
|
|
$
|
8,805
|
|
|
$
|
0.001160
|
|
|
|
7,590,362
|
|
|
LG
|
|
6/22/16
|
|
|
$
|
5,000
|
|
|
$
|
973
|
|
|
$
|
5,973
|
|
|
$
|
0.001450
|
|
|
|
4,119,414
|
|
|
GW
|
|
6/20/16
|
|
|
$
|
10,500
|
|
|
$
|
1,003
|
|
|
$
|
11,503
|
|
|
$
|
0.001450
|
|
|
|
7,933,377
|
|
|
Cerberus
|
|
6/20/16
|
|
|
$
|
5,000
|
|
|
$
|
967
|
|
|
$
|
5,967
|
|
|
$
|
0.001450
|
|
|
|
4,114,879
|
|
|
GW
|
|
6/20/16
|
|
|
$
|
6,000
|
|
|
$
|
589
|
|
|
$
|
6,589
|
|
|
$
|
0.001450
|
|
|
|
4,544,241
|
|
|
LG
|
|
6/10/16
|
|
|
$
|
6,075
|
|
|
$
|
1,134
|
|
|
$
|
7,209
|
|
|
$
|
0.001798
|
|
|
|
4,009,701
|
|
|
GW
|
|
6/9/16
|
|
|
$
|
5,000
|
|
|
$
|
479
|
|
|
$
|
5,479
|
|
|
$
|
0.001798
|
|
|
|
3,047,219
|
|
|
LG
|
|
6/2/16
|
|
|
$
|
9,000
|
|
|
$
|
848
|
|
|
$
|
9,848
|
|
|
$
|
0.002378
|
|
|
|
4,141,387
|
|
|
Cerberus
|
|
5/23/16
|
|
|
$
|
5,000
|
|
|
$
|
460
|
|
|
$
|
5,460
|
|
|
$
|
0.002436
|
|
|
|
2,241,490
|
|
|
LG
|
|
3/17/16
|
|
|
$
|
9,000
|
|
|
$
|
696
|
|
|
$
|
9,696
|
|
|
$
|
0.002436
|
|
|
|
3,980,431
|
|
|
LG
|
|
3/17/16
|
|
|
$
|
3,000
|
|
|
$
|
138
|
|
|
$
|
3,138
|
|
|
$
|
0.000638
|
|
|
|
4,918,624
|
|
|
Service
|
|
3/8/16
|
|
|
$
|
7,425
|
|
|
$
|
928
|
|
|
$
|
8,353
|
|
|
$
|
0.00174
|
|
|
|
4,800,354
|
|
|
GW
|
|
3/7/16
|
|
|
$
|
6,500
|
|
|
$
|
489
|
|
|
$
|
6,989
|
|
|
$
|
0.00174
|
|
|
|
4,016,471
|
|
|
LG
|
|
|
|
|
$
|
174,613
|
|
|
$
|
16,772
|
|
|
$
|
191,385
|
|
|
|
|
|
|
|
114,327,117
|
|
|
|
In addition to
the above during the year ended December 31, 2016, the Company:
On
November 7, 2016, the Company issued 5,000,000 shares of common stock and completed the stock purchase for the acquisition
of Sterling Classic Compassion, LLC. (“Sterling”). The Company valued the shares at $0.081 per share (the market
price of the common stock).
Preferred
Stock
On June 26, 2015,
the Company filed with the Delaware Secretary of State the Amended and Restated Designation Preferences and Rights (the “Certificate
of Designation”) of Class B Preferred Stock (the “Series B Preferred Stock”). Pursuant to the Certificate of
Designation, 1,000 shares constitute the Series B Preferred Stock. The Series B Preferred Stock and any accrued and unpaid dividends
thereon shall, with respect to rights on liquidation, winding up and dissolution, rank senior to the Company’s issued and
outstanding common stock and Series A preferred stock.
The Series
B
P
ref
e
r
red
S
tock
has the
right to vote in aggregate, on all shareholder matters equal to 51% of the total vote, no matter how many shares of common stock
or other voting stock of the Company are issued or outstanding in the future. The Series B Preferred Stock has a right to
vote on all matters presented or submitted to the Company’s stockholders for approval in pari passu with the common stockholders,
and not as a separate class. The holders of Series B Preferred Stock have the right to cast votes for each share of Series B Preferred
Stock held of record on all matters submitted to a vote of common stockholders, including the election of directors. There is
no right to cumulative voting in the election of directors. The holders of Series B Preferred Stock vote together with all other
classes and series of common stock of the Company as a single class on all actions to be taken by the common stockholders except
to the extent that voting as a separate class or series is required by law. As of December 31, 2017, and 2016, there were 1,000
shares of Class B Preferred Stock outstanding.
Warrants
and Options
On April 14,
2015, in connection with the appointment of Dr. Stephen Holt to the advisory board, the Company agreed the advisor shall receive
a non-qualified stock option to purchase 1,000,000 shares (“Option Shares”) of the Company’s common stock at
an exercise price equal to $0.05 per share and expiring April 14, 2018. Option Shares of 400,000 vested immediately and 50,000
Option Shares vested each month from April 2015 through March 2016. Accordingly, as of March 31, 2016, 1,000,000 Option Shares
have vested and the Company recorded $2,317 as stock compensation expense for the year ended December 31, 2016, based on Black-Scholes.
On April 26, 2013
and in connection with the appointment of Mr. James Canton to the Company’s advisory board, the Company issued a warrant
to Mr. Canton to purchase 300,000 shares of common stock. The warrant expired April 26, 2016.
On October 31,
2016, the Company granted (Warrant #1) to St. George the right to purchase at any time on or after November 10, 2016 (the “Issue
Date”) until the date which is the last calendar day of the month in which the fifth anniversary of the Issue Date occurs
(the “Expiration Date”), a number of fully paid and non-assessable shares (the “Warrant Shares”) of Company’s
common stock, equal to $57,500 divided by the Market Price (defined below) as of the Issue Date, as such number may be adjusted
from time to time pursuant to the terms and conditions of Warrant #1 to Purchase Shares of Common Stock. The Market Price is equal
to the lowest intra-day trade price in the twenty (20) Trading Days immediately preceding the applicable date of exercise, multiplied
by sixty percent (60%). The exercise price is the lower of $0.05 and is subject to price adjustments pursuant to the agreement
and includes a cashless exercise provision. The Company also issued Warrant #’s 2-9, with each warrant only effective upon
St. George funding of the secured notes they issued to the Company. Warrant #’s 2-9 give St. George the right to purchase
Warrant Shares equal to $27,500 divided by the Market Price on the funded date. On December 14, 2016, the Company received a payment
of $50,000, and accordingly, Warrant #2 became effective. During the year ended December 31, 2017, the Company received the funding
on the remaining notes and Warrant #’s 3-9 became effective. During the year ended December 31, 2017, the company issued
87,934,231 shares of common stock to St. George pursuant to Notices of Exercise of 9,364,108 Warrants received. The shares were
issued based upon the cashless exercise provision of the warrant.
The following table
summarizes the activity related to warrants of the Company for the years ended December 31, 2017 and 2016:
|
|
Number of Warrants
|
|
Weighted-Average Exercise Price per
share
|
|
Weighted-Average Remaining Life (Years)
|
Outstanding at January 1, 2016
|
|
|
1,300,000
|
|
|
$
|
0.05
|
|
|
|
3.00
|
|
Warrants issued
|
|
|
16,926,130
|
|
|
|
0.00564
|
|
|
|
|
|
Warrants expired
|
|
|
(300,000
|
)
|
|
|
(0.05
|
)
|
|
|
|
|
Outstanding and exercisable at December 31, 2016
|
|
|
17,926,130
|
|
|
|
0.0811
|
|
|
|
4.88
|
|
Warrant issued
|
|
|
40,573,870
|
|
|
|
0.00564
|
|
|
|
|
|
Warrants exercised
|
|
|
(9,364,108
|
)
|
|
|
0.00564
|
|
|
|
|
|
Outstanding and exercisable
at December 31, 2017
|
|
|
49,135,892
|
|
|
|
0.00654
|
|
|
|
4.17
|
|
Note 12 –
Income Taxes
The
Company accounts for income taxes under standards issued by the FASB. Under those standards, deferred tax assets and liabilities
are recognized for future tax benefits or consequences attributable to temporary differences between the financial statement carrying
amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. A valuation allowance is provided for significant deferred tax assets when it is more likely than not that such
assets will not be realized through future operations.
No
provision for federal income taxes has been recorded due to the available net operating loss carry forwards of approximately $491,107
will expire in various years through 2032. Future tax benefits which may arise as a result of these losses have not been recognized
in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded
a valuation allowance for the future tax loss carry forwards.
The
actual income tax provisions differ from the expected amounts calculated by applying the statutory income tax rate to the Company's
loss before income taxes. The components of these differences are as follows at December 31, 2017, and 2016:
|
|
2017
|
|
2016
|
Net tax loss carry-forwards
|
|
$
|
7,878,733
|
|
|
$
|
5,836,000
|
|
Statutory rate
|
|
|
37.6
|
%
|
|
|
37.6
|
%
|
Expected tax recovery
|
|
|
2,962,404
|
|
|
|
2,194,336
|
|
Change in valuation allowance
|
|
|
(2,962,404
|
)
|
|
|
(2,194,336
|
)
|
Income tax provision
|
|
$
|
—
|
|
|
$
|
—
|
|
Components of deferred tax asset:
|
|
|
|
|
|
|
|
|
Non capital tax loss carry forwards
|
|
$
|
2,962,404
|
|
|
$
|
2,194,336
|
|
Less: valuation allowance
|
|
|
(2,962,404
|
)
|
|
|
(2,194,336
|
)
|
Net deferred tax asset
|
|
$
|
—
|
|
|
$
|
—
|
|
Note 13 –
Commitments and Contingencies
Office
Space
In April 2014,
the Company entered into a two-year sublease agreement for the use of up to 7,500 square feet with a
Colorado
based
oncology clinical trial and drug testing company and facility presently doing cancer research and testing for established
pharmaceutical companies seeking FDA approval for new drugs. Pursuant to the lease, as amended, the Company agreed to pay $3,500
per month for the space. The lease expired in April 2016, and the Company owes the landlord $48,750.
In
December 2016, the Company signed a one-year lease for office space in San Juan, Puerto Rico. The lease requires monthly base
rent of $800 for the months of December 2016 through February 2017, and $900 per month for the months of March 2017 through November
2017.
In
January 2017, the Company signed a five (5) year lease, beginning February 1, 2107, for approximately 6,000 square feet of office
space, comprised of two floors, in San Juan, Puerto Rico. Pursuant to the lease, the Company will pay $3,000 per month for the
third floor of the building for the first year of the lease. The rent will increase 3% per year on February beginning in 2018
and an additional 3% per year on each successive February 1, during the term of the lease. The landlord has agreed that for the
month of February 2017, the rent will be $1,500. The rent for second floor of the building will be $2,000 per month during the
term of the lease and the Company does not have any rent payments for the first three months of the lease (February 2017 through
April 2017). Through September 30, 2017, the Company calculated the total amount of the rent for the term lease and recorded straight
line rent expense of $45,417 and had made payments of $20,516. As of December 31, 2017, the Company has a balance of $24,916 in
deferred rent which is included in the consolidated balance sheet. The leases for the second and third floor were cancelled in
September 2017 as a result of Hurricane Irma.
On December 1,
2016, the Company signed a one (1) year lease for a corporate apartment in Puerto Rico for $5,500 per month. This lease expired
in November 30, 2017.
Rent expense was
$101,279 and $40,303, respectively, and for the years ended December 31 2017, and 2016, respectively.
Leased
Properties
On
April 28, 2014, the Company executed and closed a ten-year lease agreement for 20 acres of an agricultural farming facility located
in South Florida following the approval of the so-called “Charlotte’s Web” legislation, aimed at decriminalizing
low grade marijuana specifically for the use of treating epilepsy and cancer patients. Pursuant to the lease agreement,
the Company maintains a first right of refusal to purchase the property for three years. The Company has recorded $38,244 of expense
(included in leased property expenses) for the years ended December 31, 2017, and 2016, respectively.
The
Company is currently in default of the lease agreement, as rents have not been for the second year of the lease beginning May
2015.
On
July 11, 2014, the Company signed a ten-year
lease agreement for an additional 40 acres
in Pueblo, Colorado. The lease requires monthly rent payments of $10,000 during the first year and is subject to a 2% annual increase
over the life of the lease. The lease also provides rights to 50 acres of certain tenant water rights for $50,000 annually plus
cost of approximately $2,400 annually. The Company paid the $50,000 in July 2014, and has not used the property and any water
and has not paid for any water rights after September 30, 2015. The Company has recorded $-0- of expense for the year ended December
31, 2017, and $76,650 for the year ended December 31, 2016, (included in leased property expenses). The Company is currently in
default of the lease agreement, as rents have not been paid since February 2015.
Agreements
On
April 5, 2017, the Company executed a five (5) year operational and exclusive licensing agreement with a third party
who leases a 25,000-sq. ft. approved cultivation facility located in San Juan, Puerto Rico. The Company will be the
exclusive funding source, and supervise all infrastructure buildout, equipment lease/finance, security systems and personnel
and provide access of seasoned Colorado and California cultivation crews to ensure the facility meets all standard
operating procedures as set forth by the Department Of Health of Puerto Rico. Under the agreement, the Company receives
$12,000 a month in consulting fees, licensing fees on all vaporizer and edible sales, equipment and lighting rental and
financing fees along with equity interest in the property. For the year ended December 31, 2017, the Company received $48,000
in consulting fees. As of December 31, 2017, the Company has invested $110,000.
On
August 7, 2017, the Company signed a LOI with Green Acres, whereby in consideration of consulting fees, licensing fees on all
vaporizer and edible brands, equipment and lighting rental and financing fees, the Company will provide up to $250,000
of working capital and potentially, up to $3,500,000 for the buyout of Green Acres existing mortgage on their Washington
State facility. As of December 31, 2017, the Company has invested $100,000. Repayment terms are to be from thirty percent of
Green Acres monthly EBITDA. If Green Acres does not have EBITDA in a month there will not be a payment for that month.
On October 5,
2017, the Company agreed to lease from the Company’s CEO, a "420 Style" resort and estate property
approximately one hour outside of Quebec City, Canada. The fifteen-acre estate consists of nine (9) guest suites, horse
stables, and is within walking distance to a public golf course. A separate structure will serve as a small grow facility run
by patient employees and caretakers on the property which may be toured by guests of the facility. On August 8, 2017, the
Company issued 5,000,000 shares of common stock to the seller. The Company valued the shares at $0.0123 per share (the market
price of the common stock) and has included $61,500 in stock compensation expense. The Company purchase from the seller
furniture and fixtures for $96,000. Pursuant to the agreement, the Company will pay $8,000 per month in exchange for the
Company being entitled to all rents and income generated from the property. The Company will be responsible for all costs of
the property, including, but not limited to, renovations, repairs and maintenance, insurance and utilities. As of
December 31, 2017, the Company has not made any monthly payments and also has not received any rental income from the
property, as it is currently renovating the house.
Legal &
Other
On March 2, 2015,
the Company, the Company’s CEO and the Company’s CFO at the time were named in a civil complaint filed by Erick Rodriguez
in the District Court in Clark County, Nevada (the “DCCC”). The complaint alleges that Mr. Rodriguez never received
250,000 shares of Series B preferred stock that were initially approved by the Board of Directors in 2012, subject to the completion
of a merger of a company controlled by Mr. Rodriguez. Since the merger was never completed, the shares were never certificated
to Mr. Rodriguez. On March 21, 2017, the DCC agreed to Set Aside the Entry of Default against the Defendants. Mr. Rodriguez resigned
in June 2013. On April 12, 2018, the Arbitrator issued a
final award to Rodriguez in the amount of $399,291. The Company and the Company’s counsel believe the Arbitrator denied
a number of detailed objections to the award, which cited clear mistakes as to Nevada law and to the facts. The Company has
retained a Nevada attorney who is an expert in fighting attempts to convert arbitration awards into judgments in Nevada
courts, to work with our arbitration counsel. The Company recorded a loss on legal matter, included in other expenses for the
year ended December 31, 2017.
On May 6, 2016,
the Company, B. Michael Freidman and Barry Hollander (former CFO) were named as defendants in a Summons/Complaint filed by Justin
Braune (the “Plaintiff”) in Palm Beach County Civil Court, Florida (the “PBCCC”). The complaint alleges
that Mr. Braune was entitled to shares of common stock of the Company. On December 5, 2016, the PBCCC set aside a court default
that had been previously issued. The defendants have answered the complaint, including the defenses that Mr. Braune advised the
Company’s transfer agent and the Company in his letter of resignation dated November 4, 2015, clearly stating that he has
relinquished all shares of common stock. The Company has filed a counterclaim suit against the Plaintiff, as well as sanctions
against the Plaintiff and their counsel.
Note 14 –
Going Concern
The accompanying
condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. As of December
31, 2017, the Company had an accumulated deficit of $25,578,077 and working capital deficit of $6,672,693, inclusive of a derivative
liability of $5,416,830. These conditions raise substantial doubt about the Company's ability to continue as a going concern.
The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Note 15 –
Segment Reporting
During
the year ended December 31, 2017 and 2016, the Company operated in one reportable segment, wholesale sales.
Note 16 –
Subsequent Events
On January 2, 2018,
the Company issued 2,631,579 shares of common stock upon the exercise of warrant #1 (see note 9).
On January 5, 2018,
the Company issued 4,870,000 shares of common stock upon the exercise of warrant #1 (see note 9).
On January 9, 2018,
the company received $50,000 pursuant to a Stock Purchase Agreement by and between the Company and St George.
On January 9, 2018,
St. George funded $200,000 of the secured promissory notes issued to the Company, and the Company recorded $220,000 as convertible
note payable, including $20,000 OID interest.
On January 10,
2018, the Company issued 7,500,000 shares of common stock upon the exercise of warrant #1 (see note 9).
On January 12,
2018, the Company paid $236,817 to Cerberus to redeem all of their remaining convertible notes with the Company.
On January 23,
2018, the Company issued 5,550,000 shares of common stock upon the exercise of warrant #1 (see note 9).
On January 23,
2018, the company received $100,000 pursuant to a Stock Purchase Agreement by and between the Company and St George.
On February 2,
2018, the Company issued 8,000,000 shares of common stock upon the exercise of warrant #1 (see note 9).
On February 2,
2018, the company received $100,000 pursuant to a Stock Purchase Agreement by and between the Company and St George.
On February 12,
2018, the Company issued 13,297,872 shares of common stock upon the conversion of $75,000 of principal and interest. The shares
were issued at $0.00564 per share.
On February 27,
2018, the company received $90,000 pursuant to a Stock Purchase Agreement by and between the Company and St George.
On March 20, 2018,
the company received $75,000 of the secured promissory notes issued to the Company by St George.
On March 28, 2018,
the Company issued 8,865,248 shares of common stock upon the conversion of $50,000 of principal and interest. The shares were
issued at $0.00564 per share.
F-34